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1. Introduction background {#s0005}
==========================

The World Health Organization (WHO) and the International Labour Organization (ILO) are finalizing Joint Estimates of the work-related burden of disease and injury (WHO/ILO Joint Estimates) ([@b0390]). The organizations are estimating the numbers of deaths and disability-adjusted life years (DALYs) that are attributable to selected occupational risk factors. The WHO/ILO Joint Estimates are based on already existing WHO and ILO methodologies for estimating the burden of disease for selected occupational risk factors ([@b0075], [@b0160], [@b0165], [@b0365]). They expand these existing methodologies with estimation of the burden of several prioritized additional pairs of occupational risk factors and health outcomes. For this purpose, population attributable fractions ([@b0315]) are being calculated for each additional risk factor-outcome pair, and these fractions are being applied to the total disease burden envelopes for the health outcome from the WHO *Global Health Estimates* for the years 2000--2016 ([@b0525]). Population attributable fractions are the proportional reduction in burden from the health outcome achieved by a reduction of exposure to the risk factor to zero.

The WHO/ILO Joint Estimates may include estimates of the burden of ischaemic heart disease (IHD) attributable to exposure to long working hours, if feasible, as one additional risk factor-outcome pair whose global burden of disease has not previously been estimated. To select parameters with the best and least biased evidence for our estimation models, we conducted a systematic review and meta-analysis of studies on the relationship between exposure to long working hours and IHD. We present our findings in the current paper. WHO and ILO, supported by a large network of experts, are in parallel also producing a systematic review of studies estimating the prevalence of exposure to long working hours ([@b0250]). The review of prevalence of exposure is applying novel systematic review methods (e.g., the RoB-SPEO risk of bias tool ([@b0360]). The organizations are also in parallel conducting several other systematic reviews and meta-analyses on other additional risk factor-outcome pairs ([@b0050], [@b0105], [@b0150], [@b0250], [@b0275], [@b0340], [@b0380], [@b0435], [@b0440]). To our knowledge, these are the first systematic reviews and meta-analyses (with a pre-published protocol) conducted specifically for an occupational burden of disease study ([@b0275]). The WHO's and ILO's joint estimation methodology and the WHO/ILO Joint Estimates are separate from these systematic reviews, and they will be described in more detail and reported elsewhere.

1.1. Rationale {#s0010}
--------------

To consider the feasibility of estimating the burden of IHD attributable to exposure to long working hours, and to ensure that potential estimates of burden of IHD are reported in adherence with the *Guidelines for Accurate and Transparent Health Estimates Reporting* (GATHER) ([@b0425]), WHO and ILO require a systematic review of studies on the prevalence of relevant levels of exposure to long working hours (forthcoming). The WHO and ILO also require a systematic review and meta-analysis with estimates of the relative effect of exposure to long work hours on IHD prevalence, incidence and mortality, compared with the theoretical minimum risk exposure level (the systematic review presented here). The theoretical minimum risk exposure level is the exposure level that would result in the lowest possible population risk, even if it is not feasible to attain this exposure level in practice ([@b0315]). These data and effect estimates should be tailored to serve as parameters for estimating the burden of IHD from exposure to long work hours in the WHO/ILO Joint Estimates.

We are aware of at least five prior systematic reviews on the effect of long working hours on IHD published since 2012. First, a 2012 systematic review and meta-analysis on the effect of exposure to long working hours on cardiovascular disease, which included five cohort studies and six case-control studies published up to September 2011, reported a pooled odds ratio (OR) of 1.37 (95% confidence interval (CI) 1.11--1.70) ([@b0190]). Second, a 2012 systematic review on the effect of long working hours on IHD included four prospective cohort studies and seven case-control studies published between 1966 and 19 January 2011 and reported pooled relative risks (RRs) of 1.39 (95% CI 1.12--1.72) for the prospective cohort studies and 2.43 (95% CI 1.81--3.26) for the case-control studies, respectively. Third, a 2015 systematic review, individual-participant data analysis and meta-analysis of 25 cohort studies (including 20 unpublished studies) in countries in the WHO regions of the Americas, Europe and the Western Pacific up to 20 August 2014 found a relative risk (RR) of 1.13 (95% CI 1.02--1.26; 22 cohort studies) for the effect of long working hours (≥55 h/week) on IHD ([@b0200]). Fourth, a 2018 update of the [@b0200] systematic review added one additional cohort study (i.e., the Danish Labour Force Survey) and found that exposure to working ≥55 h/week led to an increase in risk of IHD by an estimated 12% (95% CI 1.03--1.21; 23 cohort studies) ([@b0495]). Both the [@b0200] systematic review and its 2018 update combined in meta-analyses studies with non-fatal, fatal and fatal or non-fatal ("mixed") IHD events. However, burden of disease estimation requires evidence separately on IHD incidence (ideally non-fatal events only) and mortality (ideally fatal events only). Fifth, a 2019 meta-analysis included cross-sectional studies, case-control studies, and prospective cohort studies published between 1998 and 2018, and it reported that long working hours were associated with cardiovascular heart diseases (pooled OR 1.54, 95% CI 1.32--1.79) ([@b0505]). In summary, all previous systematic reviews and meta-analyses consistently concluded that working long hours increases the risk of IHD. To our knowledge, none of the prior systematic reviews had a pre-published protocol and/or missed other essential aspects of a systematic review. Our systematic review is fully compliant with latest systematic review methods (including use of a protocol) and expands the scope of the existing systematic review evidence by covering evidence from studies published up to 27 August 2019.

Our systematic review covers workers in the formal and in the informal economy. The informal economy is defined as "all economic activities by workers and economic units that are -- in law or in practice -- not covered or insufficiently covered by formal arrangements" ([@b0005]). It does not comprise "illicit activities, in particular the provision of services or the production, sale, possession or use of goods forbidden by law, including the illicit production and trafficking of drugs, the illicit manufacturing of and trafficking in firearms, trafficking in persons and money laundering, as defined in the relevant international treaties" ([@b0005]). Work in the informal economy may lead to different exposures and exposure effects than does work in the formal economy. Consequently, formality of work (informal vs. formal) may be an effect modifier of the effect of long working hours on IHD. Therefore, we consider in the systematic review the formality of the economy reported in included studies.

1.2. Description of the risk factor {#s0015}
-----------------------------------

Burden of disease estimation requires unambiguous definition of the risk factor, risk factor levels and the theoretical minimum risk exposure level. Long working hours are defined as working hours exceeding standard working hours, i.e. any working hours of ≥41 h/week ([Table 1](#t0005){ref-type="table"}). Based on results from earlier studies on long working hours and health endpoints (e.g., ([@b0200], [@b0490])), the preferred four exposure level categories for our systematic review are 35--40, 41--48, 49--54 and ≥55  h/week ([Table 1](#t0005){ref-type="table"}).Table 1Definitions of the risk factor, risk factor levels and the minimum risk exposure level.DefinitionRisk factorLong working hours (including those spent in secondary jobs), defined as working hours \>40 h/week, i.e. working hours exceeding standard working hours (35--40 h/week).Risk factor levelsFour levels:1.35--40 h/week.2.41--48 h/week.3.49--54 h/week.4.≥55 h/week.Theoretical minimum risk exposure levelStandard working hours, defined as working hours of 35--40 h/week.

The theoretical minimum risk exposure is standard working hours defined as 35--40  h/week ([Table 1](#t0005){ref-type="table"}). We acknowledge that it is possible that the theoretical minimum risk exposure might be lower than standard working hours, but working hours ≤35 h/week had to be excluded because studies indicate that some persons working less than standard hours do so because of existing health problems ([@b0200], [@b0485]). In other words, persons working less than standard hours might belong to a health-selected group or a group concerned with family care and therefore cannot serve as comparators. Consequently, if a study used as the reference group persons working less than standard hours or a combination of persons working standard hours and persons working less than standard hours, it would be excluded from the systematic review and meta-analysis. The category 35--40  h/week is the reference group used in many large studies and previous systematic reviews ([@b0190], [@b0485]).

1.3. Definition of the outcome {#s0020}
------------------------------

The *WHO Global Health Estimates* group outcomes into standard burden of disease categories ([@b0520]), based on standard codes from the *International Statistical Classification of Diseases and Related Health Problems 10th Revision* (ICD-10) ([@b0515]). The relevant *WHO Global Health Estimates* category for this systematic review is "II.H.2 Ischaemic heart disease" ([@b0520]). In line with the *WHO Global Health Estimates*, we define the health outcome covered in this systematic review as IHD, defined as conditions with ICD-10 codes I20 to I25 ([Table 2](#t0010){ref-type="table"}). [Table 2](#t0010){ref-type="table"} shows that this review covers all the relevant categories of diseases or health problems included in the *WHO Global Health Estimates* category.Table 2ICD-10 codes and disease and health problems covered by the WHO Global Health Estimates categories "II.H.2 Ischaemic heart disease" and their inclusion in the systematic review.ICD-10 codeDisease or health problemIncluded in this reviewI20Angina pectorisYesI21Acute myocardial infarctionYesI22Subsequent myocardial infarctionYesI23Certain current complications following acute myocardial infarctionYesI24Other acute ischaemic heart diseasesYesI25Chronic ischaemic heart diseaseYes

1.4. How the risk factor may impact the outcome {#s0025}
-----------------------------------------------

[Fig. 1](#f0005){ref-type="fig"} presents the logic model for our systematic review of the causal relationship between exposure to long working hours and IHD, taken from our protocol ([@b0250]). This logic model is an a priori, process-orientated one ([@b0370]) that seeks to capture the complexity of the risk factor--outcome causal relationship ([@b0010]).Fig. 1Logic model of the possible causal relationship between exposure to long working hours and ischaemic heart disease.

Theoretically, distinct social contexts in the world of work are likely to exacerbate or mitigate the effect of exposure to long working hours on IHD risk. While empirical tests of this assumption are not available, these contexts can exert a direct effect on working hours. Evidence suggests that economic globalization drives people around the world to work longer hours ([@b0245]).

Based on knowledge of previous research on long working hours and IHD ([@b0200], [@b0490]), we assume that the effect of exposure to long working hours on IHD could be modified by country (or WHO region), sex, age, industrial sector, occupation, socioeconomic position and formality of the economy. Three important individual-level variables, age, sex and socioeconomic position (usually assessed by income, education or occupational grade) have been included in several previous studies as confounding factors, given the probability of differential exposure and effect modification by these variables. Up to now, there is no empirical evidence on potential interactions between them, nor do we know to what extent they do modify the effect of long working hours on IHD (an example would be that the effect is stronger among participants with low socioeconomic position due to their increased general susceptibility). These three variables were analyzed in this systematic review, whenever available. Exceptions are accepted for studies whose study samples were homogenous (such as men only) or that conducted sensitivity analyses to test the presence of confounding (such as sex-disaggregated analyses that can help identify confounding by sex).

Several variables may mediate the effects of this exposure on disease risk through two major pathways. The first one concerns behavioural responses that result in an increase in health-adverse behaviours, such as cigarette smoking, high alcohol consumption, unhealthy diet and physical inactivity. These behaviours are established risk factors of IHD ([@b0430], [@b0490]). Moreover, impaired sleep and poor recovery resulting from this exposure increase the risk of IHD ([@b0415], [@b0475]). Chronic psychosocial stress responses define a second pathway mediating the effects of exposure on IHD. According to established physiological evidence, recurrent high effort (exposure) results in continued activation of the autonomic nervous/immune systems and associated stress axes, the sympatho-adrenal medullary and the hypothalamic-pituitary adrenal axes, with excessive release of respective stress hormones (i.e., adrenalin, noradrenalin and cortisol) ([@b0035], [@b0170], [@b0320]). In the longer run, this recurrent activation exceeds the regulatory capacity of the cardiovascular system, thus triggering functional dysregulations (e.g., disturbed sympatho-vagal balance resulting in low heart rate variability, sustained high blood pressure) and structural lesions (e.g., atherogenesis in coronary vessels) ([@b0210]). Importantly, some experiments representing psychosocial stress at work (e.g., high work pressure, unfair pay) demonstrated direct effects on indicators of cardiovascular dysregulation (e.g., reduced heart rate variability; [@b0070], [@b0085]). Extended exposure to these conditions, as is the case with long working hours, promotes cardiovascular disease susceptibility by the processes identified in the 'allostatic load' model ([@b0280]).

In addition to epidemiological, clinical and experimental evidence suggesting that chronic psychosocial stress (including that from working long hours) presents a risk factor of IHD, there is indirect evidence on its causal role from animal studies. In classical experiments with cynomolgus macaques, a direct effect of exposure to a chronic psychosocial stressor on growth of atherosclerotic plaques in coronary vessels was demonstrated, and this process was prevented by administration of beta-adrenergic blocking agents ([@b0195]).

2. Objectives {#s0030}
=============

To systematically review and meta-analyse evidence on the effect of exposure to long working hours (three categories: 41--48, 49--54 and ≥55 h/week) on IHD prevalence, incidence and mortality among workers of working age, compared with the minimum risk exposure level (standard working hours: 35--40 h/week).

3. Methods {#s0035}
==========

3.1. Developed protocol {#s0040}
-----------------------

We applied the Navigation Guide ([@b0510]) methodology for systematic reviews in environmental and occupational health as our guiding methodological framework, wherever feasible. The guide applies established systematic review methods from clinical medicine, including standard Cochrane methods for systematic reviews of interventions, to the field of environmental and occupational health. The methods ensure systematic and rigorous evidence synthesis on environmental and occupational risk factors that reduces bias and maximizes transparency ([@b0510]). The need for further methodological development and refinement of the relatively novel Navigation Guide has been acknowledged ([@b0510]). From the perspective of the Navigation Guide framework, all steps were conducted (i.e., steps 1--6 in Fig. 1 in ([@b0510]) for the stream on human data and none of the steps for the stream on non-human data, although we narratively synthesized the mechanistic evidence from non-human data that we were aware of ([Section 1.4](#s0025){ref-type="sec"}).

We registered the protocol in PROSPERO under CRD42017084243. The protocol adheres to the preferred reporting items for systematic review and meta-analysis protocols statement (PRISMA-P) ([@b0295], [@b0405]), with the abstract adhering to the reporting items for systematic reviews in journal and conference abstracts (PRISMA-A) ([@b0030]). Any modification of the methods stated in the protocol was registered in PROSPERO and reported in the systematic review itself ([Section 8](#s0475){ref-type="sec"}). Our systematic review is reported according to the preferred reporting items for systematic review and meta-analysis statement (PRISMA) ([@b0260]). Our reporting of the parameters for estimating the burden of IHD to long working hours in the systematic review adheres to the requirements of the GATHER guidelines ([@b0425]). This is done because the WHO/ILO burden of disease estimates that may be produced following the systematic review must also adhere to these reporting guidelines.

3.2. Searched literature {#s0045}
------------------------

### 3.2.1. Electronic databases {#s0050}

We searched the six following electronic databases:1.WHO International Clinical Trials Registry Platform (to 6 July 2018).2.Ovid MEDLINE(R) Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) 1946 to Present (1 January 1946 to 27 August 2019).3.Scopus (1 January 1995 to 6 July 2018).4.Web of Science (1 January 1900 to 6 July 2018).5.CISDOC archived database (1901--2012 searched on 6 July 2018).6.PsycINFO Ovid (1 January 1880 to 6 July 2018)

The Ovid MEDLINE search strategy was presented in the protocol ([@b0250]). The full search strategies for all databases were revised by an information scientist and are presented in Appendix 3 in the [Supplementary data](#s0505){ref-type="sec"}. Searches were performed in electronic databases operated in the English language using a search strategy in the English language. When we neared completion of the review, we conducted a top-up search of the MEDLINE database on 27th August 2019 to capture the most recent publications (e.g., publications ahead of print). Deviations from the proposed search strategy and the actual search strategy are documented in [Section 8](#s0475){ref-type="sec"}.

### 3.2.2. Grey literature databases {#s0055}

We also searched the two following two grey literature databases in July 2018;OpenGrey (<http://www.opengrey.eu/>)Grey Literature Report (<http://greylit.org/>)

We used the following search strategy: (("work hours" OR "working hours" OR "long work" OR "long working" OR "long hours" OR overtime OR overwork OR workload OR employee\*) AND (myocardial OR heart OR coronary OR cardiovascular OR angina)).

### 3.2.3. Internet search engines {#s0060}

We also searched the Google ([www.google.com/](http://www.google.com/){#ir015}) and Google Scholar ([www.google.com/scholar/](http://www.google.com/scholar/){#ir020}) Internet search engines and screened the first 100 hits for potentially relevant records, as was previously done ([@b0350], [@b0355]).

### 3.2.4. Organizational websites {#s0065}

The websites of the seven following international organizations and national government departments were searched on the 15th September 2018 using the keywords "myocardial", "coronary", "cardiovascular", "heart":1.International Labour Organization (www.ilo.org/).2.World Health Organization (www.who.int).3.European Agency for Safety and Health at Work (<https://osha.europa.eu/en>).4.Eurostat (<http://www.ec.europa.eu/eurostat/web/main/home>).5.China National Knowledge Infrastructure (<http://www.cnki.net/>).6.Finnish Institute of Occupational Health (<https://www.ttl.fi/en/>).7.United States National Institute for Occupational Safety and Health (NIOSH) of the United States of America, using the NIOSH data and statistics gateway (<https://www.cdc.gov/niosh/data/>).

### 3.2.5. Hand-searching and expert consultation {#s0070}

We hand-searched for potentially eligible studies in:•Reference lists of previous systematic reviews.•Reference lists of all included trials register records.•Study protocols published over the past 24 months in the three peer-reviewed academic journals with the largest number of included studies.•Published study protocols that have cited the included studies (identified in Web of Science citation database).•Collections of the review authors.

Additional experts were contacted with a list of included studies, with the request to identify potentially eligible additional studies.

3.3. Selected studies {#s0075}
---------------------

Study selection was carried out with the Covidence software ([@b0465]). All records identified in the search were downloaded and duplicates were identified and deleted. Afterwards, two review authors independently and in duplicate screened titles and abstracts (step 1) and then full texts (step 2) of potentially relevant records. A third review author resolved any disagreements between the two review authors. If a study record identified in the literature search was authored by a review author assigned to study selection or if an assigned review author was involved in the study, the record was re-assigned to another review author for study selection. The study selection is presented in a flow chart, as per PRISMA guidelines ([@b0260]).

3.4. Eligibility criteria {#s0080}
-------------------------

The PECO ([@b0305]) criteria are described below.

### 3.4.1. Types of populations {#s0085}

We included studies of the working-age population (≥15 years) in the formal and informal economy. Studies of children (aged \< 15 years) and unpaid domestic workers were excluded. Participants residing in any WHO and/or ILO Member State and any industrial setting or occupational group were included. Exposure to long working hours may potentially have further population reach (e.g., across generations for workers of reproductive age) and acknowledged that the scope of our systematic review does not capture these populations and impacts on them. Our protocol paper (in Appendix F) provides a complete, but briefer overview of the PECO criteria ([@b0250]).

### 3.4.2. Types of exposures {#s0090}

We included studies that defined long working hours in accordance with our standard definition ([Table 1](#t0005){ref-type="table"}). We again prioritized measures of the total number of hours worked, including in both of: main and secondary jobs, self-employment and salaried employment, whether in the informal or the formal economy. We included studies with objective (e.g., by means of time recording technology) or subjective measurements of long working hours, whether, including studies that used measurements by experts (e.g., scientists with subject matter expertise) and self-reports by the worker, workplace administrator or manager. If a study presented both objective and subjective measurements, then we prioritized objective ones. Studies with measures from any data source, including registry data, were included.

For studies that reported exposure levels differing from our standard levels ([Table 1](#t0005){ref-type="table"}), we converted the reported levels to the standard levels if possible, and reported analyses on these alternate exposure levels if impossible.

### 3.4.3. Types of comparators {#s0095}

The included comparator were participants exposed to the theoretical minimum risk exposure level: worked 35--40 h/week ([Table 1](#t0005){ref-type="table"}). We excluded all other comparators.

### 3.4.4. Types of outcomes {#s0100}

This systematic review included three outcomes:1.Has IHD (or, in other words, IHD prevalence).2.Acquired IHD (IHD incidence).3.Died from IHD (IHD mortality).

We included studies that define IHD in accordance with our standard definition ([Table 2](#t0010){ref-type="table"}). Other coronary-related unspecific symptoms (e.g., chest pain) were excluded. We did, however, include the outcome definition of IHD via a proxy term of heart trouble, given the fact that approximately 80% of heart disease is IHD, while at the same time acknowledging that heart trouble includes other small portion of heart conditions such as hypertensive heart disease, rheumatic heart disease, and inflammatory heart disease ([@b0290]). This outcome definition has also been included in previous systematic reviews and meta-analyses of the effect of working long hours on IHD, including the ([@b0200]) one. We expected that most studies examining exposure to long working hours and its effect on IHD have documented ICD-10 diagnostic codes. In the remaining cases, methods that approximate ICD-10 criteria ascertained the outcome, such as physician-diagnosed self-reports (see also Appendix 4 in the [supplementary data](#s0505){ref-type="sec"} and [Section 5.3](#s0450){ref-type="sec"}. *Limitations of this systematic review*).

The following measurements of IHD are regarded as eligible:i.Diagnosis by a physician with imaging.ii.Hospital discharge records.iii.Other relevant administrative data (e.g., records of sickness absence or disability).iv.Medically certified cause of death.

All other measures were excluded from this systematic review.

Objective (e.g., health records) and subjective (e.g., self-reports) measures of the outcome are eligible. If a study presents both objective and subjective measurements, then the objective ones were prioritized.

Studies with "mixed" outcome definitions (i.e., including both fatal IHD events and non-fatal IHD events) provide evidence on both the outcome IHD incidence and the outcome IHD mortality. These studies were consequently included in analyses on both of these outcomes, as long as they were sufficiently heterogeneous statistically with studies of non-fatal events only and fatal events only, respectively (as determinded by sensitivity analyses; [Section 3.9](#s0135){ref-type="sec"}).

### 3.4.5. Types of studies {#s0105}

We included studies that investigated the effect of long working hours on IHD for any years. Eligible study designs were randomized controlled trials (including parallel-group, cluster, cross-over and factorial trials), cohort studies (both prospective and retrospective), case-control studies, and other non-randomized intervention studies (including quasi-randomized controlled trials, controlled before-after studies and interrupted time series studies). We included a broader set of observational study designs than is commonly included, because a recent augmented Cochrane Review of complex interventions identified valuable additional studies using such a broader set of designs ([@b0015]). As we have an interest in quantifying risk and not in qualitative assessment of hazard ([@b0025]), all other study designs were excluded (e.g., uncontrolled before-and-after, cross-sectional, qualitative, modelling, case and non-original studies).

Records published in any year and any language were included. Again, the search was conducted using English language terms, so that records published in any language that present essential information (i.e. title and abstract) in English were included. If a record was written in a language other than those spoken by the authors of this review or those of other reviews ([@b0050], [@b0105], [@b0150], [@b0275], [@b0340], [@b0380], [@b0435], [@b0440]) in the series (i.e. Arabic, Bulgarian, Chinese, Danish, Dutch, English, French, Finnish, German, Hungarian, Italian, Japanese, Norwegian, Portuguese, Russian, Spanish, Swedish and Thai), then the record was translated into English. Published and unpublished studies were included. Studies conducted using unethical practices were excluded (e.g., studies that deliberately exposed humans to a known risk factor to human health).

### 3.4.6. Types of effect measures {#s0110}

We included measures of the relative effect of a relevant level of long working hours on the risk of IHD (prevalence, incidence and mortality), compared with the theoretical minimum risk exposure level. We included relative effect measures such as RRs, ORs and hazard ratios for both incidence measures and mortality measures (e.g., developed or died from IHD). Measures of absolute effects (e.g., mean differences in risks or odds) were converted into relative effect measures, but if conversion was impossible, they were excluded. To ensure comparability of effect estimates and to facilitate meta-analysis, if a study presented an OR, then it was converted into an RR, if possible, using the guidance provided in the Cochrane handbook for systematic reviews of interventions ([@b0140]).

If a study presented estimates for the effect from two or more alternative models that had been adjusted for different variables, then we systematically prioritized the estimate from the model that provided information on the relevant confounders or mediators, at least the core variables defined in [Fig. 1](#f0005){ref-type="fig"}: age, sex, and socioeconomic position. We prioritized estimates from models adjusted for more potential confounders over those from models adjusted for fewer. For example, if a study presents estimates from a crude, unadjusted model (Model A), a model adjusted for one potential confounder (e.g., age; Model B) and a model adjusted for two potential confounders (e.g., age and sex; Model C), then we prioritized the estimate from Model C. We prioritized estimates from models unadjusted for mediators over those from models that adjusted for mediators, because adjustment for mediators can introduce bias. For example, if Model A has been adjusted for two confounders, and Model B has been adjusted for the same two confounders and a potential mediator, then we chose the estimate from Model A over that from Model B. We prioritized estimates from models that can adjust for time-varying confounders that are at the same time also mediators, such as marginal structural models ([@b0345]), over estimates from models that can only adjust for time-varying confounders, such as fixed-effects models ([@b0115]). Similarly, we prioritized estimates from models that adjust for time-varying confounders over models that do not adjust for time-varying confounding. If a study presents effect estimates from two or more potentially eligible models, then we documented why we prioritized the selected model.

3.5. Extracted data {#s0115}
-------------------

A standard data extraction form was developed and trialled until data extractors reached convergence and agreement. At least two review authors independently extracted data on study characteristics (including study authors, study year, study country, participants, exposure and outcome), study design (including study type, comparator, epidemiological model(s) used and effect estimate measure) and risk of bias (including source population representation, blinding, exposure assessment, outcome assessment, confounding, incomplete outcome data, selective outcome reporting, conflict of interest and other sources of bias). A third review author resolved conflicts in data extraction. Data were entered into and managed with Excel.

We also extracted data on potential conflict of interest in included studies. For each author and affiliated organization of each included study record, their financial disclosures and funding sources were extracted. We used a modification of a previous method to identify and assess undisclosed financial interest of authors ([@b0095]). Where no financial disclosure or conflict of interest statements were available, the names of all authors were searched in other study records gathered for this study and published in the prior 36 months and in other publicly available declarations of interests ([@b0060], [@b0065]).

3.6. Requested missing data {#s0120}
---------------------------

We requested missing data from the principal study author by email or phone, using the contact details provided in the principal study record. If we did not receive a positive response from the study author, follow-up emails were sent twice, at two and four weeks. We present a description of missing data, the study author from whom the data were requested, the date of requests sent, the date on which data were received (if any), and a summary of the responses provided by the study authors (Appendix 1 in the [Supplementary data](#s0505){ref-type="sec"}). If we did not receive some or all of the requested missing data, we nevertheless retained the study in the systematic review as long as it fulfilled our eligibility criteria.

3.7. Assessed risk of bias {#s0125}
--------------------------

Standard risk of bias tools do not exist for systematic reviews for hazard identification or those for risk assessment in occupational and environmental health. The five such tools developed specifically for occupational and environmental health are for either or both hazard identification and risk assessment, and they differ substantially in the types of studies (randomized, observational and/or simulation studies) and data (e.g., human, animal and/or *in vitro*) they seek to assess ([@b0375]). However, all five tools, including the Navigation Guide one ([@b0240]), assess risk of bias in human studies similarly ([@b0375]).

Consistent with using the Navigation Guide as our organizing framework, we used its risk of bias tool, which builds on the standard risk of bias assessment methods of Cochrane ([@b0135]) and the US Agency for Healthcare Research and Quality ([@b0500]). Some further refinements of the Navigation Guide method may be warranted ([@b0110]), but it has been successfully applied in several completed and ongoing systematic reviews ([@b0180], [@b0185], [@b0215], [@b0220], [@b0225], [@b0230], [@b0235], [@b0470]). In our application of the Navigation Guide method, we draw heavily on one of its latest versions, as presented in the protocol for an ongoing systematic review ([@b0240]).

Risk of bias was assessed on the individual study level and across the body of evidence for each outcome. The nine risk of bias domains included in the Navigation Guide method for human data were: (i) source population representation; (ii) blinding; (iii) exposure assessment; (iv) outcome assessment; (v) confounding; (vi) incomplete outcome data; (vii) selective outcome reporting; (viii) conflict of interest; and (ix) other sources of bias. Risk of bias or confounding ratings for all domains were: "low"; "probably low"; "probably high"; "high" or "not applicable" ([@b0240]). To judge the risk of bias in each domain, we applied a priori instructions ([@b0250]), which were adapted from an ongoing Navigation Guide systematic review ([@b0240]), and further described in our protocol ([@b0250]). For example, a study was assessed as carrying "low" risk of bias from source population representation, if we judge the source population to be described in sufficient detail (including eligibility criteria, recruitment, enrolment, participation and loss to follow up) and the distribution and characteristics of the study sample to indicate minimal or no risk of selection effects.

All risk of bias assessors jointly trialled the application of the risk of bias criteria until they had synchronized their understanding and application of these criteria. Two or more study authors independently judged (or assessed) the risk of bias for each study by outcome. Where individual assessments differed, a third author resolved the conflict. For each included study, we reported our risk of bias assessment at the level of the individual study by domain in a standard 'Risk of bias table' ([@b0135]). For the entire body of evidence, we presented the study-level risk of bias ratings by domains in a 'Risk of bias summary figure' (or 'Risk of bias matrix') ([@b0135]).

3.8. Synthesised evidence (including conducted meta-analysis) {#s0130}
-------------------------------------------------------------

We conducted separate meta-analyses for all outcomes: Has IHD, Acquired IHD, and Died from IHD. Studies of different designs were not combined quantitatively. If we found two or more studies with an eligible effect estimate, two or more review authors independently investigated the clinical heterogeneity ([@b0045]) of the studies in terms of participants (including country, sex, age and industrial sector or occupation), level of risk factor exposure, comparator and outcomes, following our protocol ([@b0250]). If we found that effect estimates differed considerably by WHO region, sex and/or age, or a combination of these, then evidence was synthesized for the relevant populations defined by WHO region, sex and/or age, or combination thereof. If we found effect estimates to be clinically homogenous across WHO regions, sex and age groups, then we combined studies from all of these populations into one pooled effect estimate that can be applied across all combinations of WHO regions, sexes and age groups in the WHO/ILO Joint Estimates.

If we judged two or more studies for the relevant combination of WHO region, sex and age group, or combination thereof, to be sufficiently clinically homogenous to potentially be combined quantitatively using quantitative meta-analysis, then the statistical heterogeneity of the studies was tested using the I^2^ statistic ([@b0090]). If two or more clinically homogenous studies were found to be sufficiently homogenous statistically to be combined in a meta-analysis, we pooled the RRs of the studies in a quantitative meta-analysis, using the inverse variance method with a random effects model to account for cross-study heterogeneity ([@b0090]). The meta-analysis was conducted in RevMan 5.3.

We neither quantitatively combined data from studies with different designs (e.g., did not combine cohort studies with case-control studies), nor did we combine unadjusted with adjusted models. We only combined studies that we judged to have a minimum acceptable level of adjustment for the three core confounders identified ([Fig. 1](#f0005){ref-type="fig"}, [Section 3.4.5](#s0105){ref-type="sec"}).

If we found studies with "pure" outcome definitions (i.e. capturing exclusively either non-fatal or fatal IHD events) and "mixed" outcome definitions (i.e. capturing any IHD events, whether non-fatal [or]{.ul} fatal), then we conducted "exploratory subgroup analyses" in which we sub-grouped studies by "pure" versus "mixed" outcome definitions. Before conducting these analyses, we formulated the following rules for determining inclusion of these studies in quantitative meta-analyses:•If there was no evidence for (meaningful) subgroup differences, then we would pool studies with "mixed" and "pure" outcome definitions.•If there was evidence for (meaningful) subgroup differences, then we would not pool studies with "mixed" and "pure" outcome definitions.

If quantitative synthesis was not feasible (for instance, due to different exposure levels as defined above), the study findings were synthesized narratively and we identified the estimates that we judged to be the highest quality evidence available.

3.9. Conducted subgroup and sensitivity analyses {#s0135}
------------------------------------------------

Subgroup analyses were conducted only for the main meta-analysis and comparison of interest (i.e., the meta-analysis of cohort studies for the comparison of worked ≥55 h/week versus worked 35--40 h/week). We conducted subgroup analyses by:•WHO region.•Sex.•Age group.•SES.

We also planned to conduct subgroup analyses by occupation, industrial sector and formality of economy, but did not find evidence or receive missing data to populate these subgroup analyses.

We conducted the following sensitivity analyses:•Studies with exclusively non-fatal or fatal IHD events, compared with studies with "mixed" (non-fatal and/or fatal) IHD events.•Studies judged to be of "high"/"probably high" risk of bias in any domain, compared with "low"/"probably low" risk of bias in all domains.•Studies with documented or approximated ICD-10 diagnostic codes (e.g., as recorded in administrative health records), compared with studies without ICD-10 diagnostic codes (e.g., self-reports).

We planned to also compare studies with "low" or "probably low" risk of bias from conflict of interest with studies with any "high" or "probably high" risk of bias in this domain. However, we did not conduct such sensitivity analyses because we rated no included study to have any such risk of bias from conflict of interest.

3.10. Assessed quality of evidence {#s0140}
----------------------------------

We assessed quality of evidence using a modified version of the Navigation Guide quality of evidence assessment tool ([@b0240]). The tool is based on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach ([@b0400]) adapted specifically to systematic reviews in occupational and environmental health ([@b0300]).

At least two review authors assessed quality of evidence for the entire body of evidence by outcome, with any disagreements resolved by a third review author. We adapted the latest Navigation Guide instructions ([@b0240]) for grading the quality of evidence and presented the adapted instructions in our protocol ([@b0250]). We downgraded the quality of evidence for the following five reasons: (i) risk of bias; (ii) inconsistency; (iii) indirectness; (iv) imprecision; and (v) publication bias ([@b0020]). These items were considered downgrades if they could not be explained. If our systematic review had included ten or more studies, we aimed to generate an Egger's funnel plot to judge concerns on publication bias. If it included nine or fewer studies, we judged the risk of publication bias qualitatively.

We graded the quality of the entire body of evidence by outcome, using the three Navigation Guide standard quality of evidence ratings: "high", "moderate" and "low" ([@b0240]). Within each of the relevant domains, the concern was rated for the quality of evidence, using the ratings "none", "serious" and "very serious". As per Navigation Guide, we started at "high" for randomized studies and "moderate" for observational studies. Quality was downgraded if there was no concern by nil grades (0), for a serious concern by one grade (-1) and for a very serious concern by two grades (-2). We upgraded the quality of evidence for the following other reasons: large effect, dose--response and plausible residual confounding and bias. There had to be compelling reasons to upgrade or downgrade. If we had a serious concern for risk of bias in a body of evidence consisting of observational studies (-1), but had no other concerns, and had no reasons for upgrading, then we downgraded the quality of evidence by one grade from "moderate" to "low".

3.11. Assessed strength of evidence {#s0145}
-----------------------------------

Our systematic review included observational epidemiologic studies of human data only, and no other streams of evidence (e.g., no studies of non-human data). The standard Navigation Guide methodology ([@b0240]) allows for rating human and non-human animal studies separately, and then combining the strength of evidence for each stream for an overall strength of evidence rating. However, the Navigation Guide also allows for rating one stream of evidence based on the factors described above (i.e., risk of bias, indirectness, inconsistency, imprecisions, publication bias, large magnitude of effect, dose--response and residual confounding) to arrive at an overall rating of the quality of evidence as 'high', 'moderate' or 'low' (see above and the protocol). The approach of evaluating only the human evidence stream is consistent with the GRADE methodology that has adopted the Bradford Hill considerations ([@b0395]). So, using the method above based on the Navigation Guide incorporates the considerations of Bradford Hill ([Table 3](#t0015){ref-type="table"}).Table 3Bradford Hill considerations and their relationship to GRADE and the Navigation Guide for evaluating the overall quality of the evidence for human observational studies.Bradford HillGRADENavigation GuideStrengthStrength of association and imprecision in effect estimateStrength of association and imprecision in effect estimateConsistencyConsistency across studies, i.e., across different situations (different researchers)Consistency across studies, i.e., across different situations (different researchers)TemporalityStudy design, properly designed and conducted observational studiesStudy design, properly designed and conducted observational studiesBiological GradientDose response gradientDose response gradientSpecificityIndirectnessIndirectnessCoherenceIndirectnessIndirectnessExperimentStudy design, properly designed and conducted observational studiesStudy design, properly designed and conducted observational studiesAnalogyExisting association for critical outcomes leads to not downgrading the quality, indirectnessExisting association for critical outcomes leads to not downgrading the quality, indirectness. Evaluating the overall strength of body of human evidence allows consideration of other compelling attributes of the data that may influence certainty.[^2]

There is an additional step that is described in the protocol that integrates the quality of the evidence (method for assessing described above) with other elements including direction of effect and confidence in the effect and other compelling attributes of the data. These attributes may influence our certainty to allow for an overall rating that consists of "sufficient evidence of toxicity/harmfulness", "limited of toxicity/harmfulness", "inadequate of toxicity/harmfulness" and "evidence of lack of toxicity/harmfulness" based on human evidence. This approach to evaluate only the human evidence has been applied in previous systematic reviews ([@b0240], [@b0230]) and verified by the US National Academy of Sciences ([@b0325]). It also provides two steps that integrate Bradford Hill criteria (evaluating the quality of the evidence and then evaluating the overall strength of evidence). Finally, the GRADE quality of evidence ratings (which are the same as for Navigation Guide) are analogous to the final ratings from Bradford Hill for causality which has been described in [@b0395] ([Table 4](#t0020){ref-type="table"}).Table 4Interpretation of the GRADE ratings of the overall quality of evidence and the Navigation Guide ratings for strength of evidence evaluation.GRADE rating for quality of evidenceInterpretation of GRADE ratingNavigation Guide rating for strength of evidence for human evidenceInterpretation of Navigation Guide ratingHighThere is high confidence that the true effect lies close to that of the estimate of the effect.Sufficient evidence of toxicityA positive relationship is observed between exposure and outcome where chance, bias, and confounding can be ruled out with reasonable confidence. The available evidence includes results from one or more well-designed, well conducted studies, and the conclusion is unlikely to be strongly affected by the results of future studies.ModerateThere is moderate confidence in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.Limited evidence of toxicityA positive relationship is observed between exposure and outcome where chance, bias, and confounding cannot be ruled out with reasonable confidence. Confidence in the relationship is constrained by such factors as: the number, size, or quality of individual studies, or inconsistency of findings across individual studies. As more information becomes available, the observed effect could change, and this change may be large enough to alter the conclusion.LowThe panel's confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effectInadequate evidence of toxicityThe available evidence is insufficient to assess effects of the exposure. Evidence is insufficient because of: the limited number or size of studies, low quality of individual studies, or inconsistency of findings across individual studies. More information may allow an assessment of effects.Very LowThere is little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.[^3]

4. Results {#s0150}
==========

4.1. Study selection {#s0155}
--------------------

Of the total of 4,631 individual study records identified in our searches, 19 records reporting results from 37 studies fulfilled the eligibility criteria and were included in the systematic review ([Fig. 2](#f0010){ref-type="fig"}). For the 45 excluded studies that most closely resembled inclusion criteria, the reasons for exclusion are listed in Appendix 2 in the [Supplementary data](#s0505){ref-type="sec"}. Of the 37 included studies, 35 studies were included in one or more quantitative meta-analyses ([Fig. 2](#f0010){ref-type="fig"}).Fig. 2Flow diagram of study selection.

4.2. Characteristics of included studies {#s0160}
----------------------------------------

The characteristics of the included studies are summarized in [Table 5](#t0025){ref-type="table"}.Table 5Characteristics of included studies in the systematic review of long working hours and ischaemic heart disease.(Part I: study population and study type)StudyStudy populationStudy typeStudy IDTotal number of study participantsNumber of female study participantsCountry of study populationGeographic location (specify as \'national\' or list regions or sites)Industrial sector (specify ISIC-4 code provided in worksheet "Industrial sector codes")Occupation (specify ISCO-08 code provided in worksheet "Occupation code")AgeStudy designStudy period (month of first collection of any data and month of last collection of any data)Follow-up period (period in months between exposure and outcome)Virtanen 2012 - Russek 1958200 (100 cases and 100 controls)3 or more unclearUnited StatesNot reportedNot reportedNot reported20--45 yearsCase-control study1948--1958N/AVirtanen 2012 - [@b0450]171 (62 cases and 109 controls)0SwedenLocalNot reportedNot reportedMean age: cases 56 years, controls 53 yearsCase-control studyJanuary 1966 to January 1970N/AVirtanen 2012 - [@b0455]100 (50 MI case and 50 control)0United StatesLocalNot reportedNot reported40--60 yearsCase-control studyUnclearN/AVirtanen 2012 - Falger 1992458 (133 cases, 133 neighbourhood controls and 192 hospital controls)0NetherlandsRegionNot reportedNot reportedMean age: cases 53.1 years, neighbourhood controls 49.2 years, hospital controls 51.1 yearsCase-control studyUnclearN/AVirtanen 2012 - [@b0410]526 (195 cases, 331 controls)0JapanNot reportedNot reportedNot reportedMean age: cases 55.5 years, controls 54.4 yearsCase-control studyNovember 1990 to November 1993N/AVirtanen 2012 - [@b0265]705 (260 cases and 445 controls)0JapanLocalNot reportedNot reported40--79 yearsCase-control studySeptember 1996 to March 1999N/AVirtanen 2012 - Fukuoka 200594 (47 cases; 47 controls)2JapanRegionNot reportedNot reportedMean age: cases 52 years, controls 50 yearsCase-control study2002N/AJeong 2013868 (99 cases; 769 controls)149 (male 82.8%)Korea, Republic ofNot reportedNot reportedNot reportedMean age: cases 49.5 years, controls 49.8 yearsCase-control studyNovember 2009 to October 2011N/A[@b0040]966 (322 cases and 644 controls)0China (Taiwan)RegionNot reportedNot reportedcases: 26--64 years\
controls: 27--64 yearsCase-control studyJanuary 2008 - November 2011 (cases). September 2007 (controls)N/A[@b0270]595 (354 cases and 241 controls)189ChinaLocalNot reportedNot reportedMean age:\
cases 55.28 years\
controls 51.94 yearsCase-control studyDecember\
\
2015 to November 2016N/A[@b0285]692 (116 cases and 576 controls)215United StatesNationalNot reportedNot reportedMean age:\
cases 53.7 years\
controls 53.8 yearsCase-control study1996 to 2000N/AKivimaki 2015 - [@b0480]60141752United KingdomLocal84 Public administration and defence; compulsory social securityNot reportedMean age 48.7 years at baselineProspective cohort study1991--1994 (baseline) to 2002--200411 yearsKivimaki 2015 - [@b0330]1146595DenmarkLocalNot reportedNot reportedMean age 47.0 years at baselineProspective cohort studyJanuary 1993-June 1994 (baseline) to July 200713 to 14.5 yearsKivimaki 2015 - Holtermann 201049430DenmarkRegionNot reportedNot reportedMean age 48.6 years at baselineProspective cohort study1970--1971 (baseline) to end of 200130 yearsKivimaki 2015 - [@b0460]88383126IsraelLocalNot reportedNot reportedMean age 44.9 years at baselineProspective cohort study2003--2008 (baseline) to December 2010Averagely 3.6 years (12 months to 8 years)Kivimaki 2015 - O\'Reilly 2013414,949144,938United KingdomRegionNot reportedNot reportedMean age 39.0 years at baselineProspective cohort study2001 (baseline) to 20098.7 yearsKivimaki 2015 - WOLF-S 199255542395SwedenRegionNot reportedNot reportedMean age 41.5 years at baselineProspective cohort study1992--1995 (baseline)unclearKivimaki 2015 - Belstress 199411,6850BelgiumNationalNot reportedNot reportedMean age 45.8 years at baselineProspective cohort study1994--1998 (baseline)unclearKivimaki 2015 - WOLF-N 19964648772SwedenRegionNot reportedNot reportedMean age 44.0 years at baselineProspective cohort study1996--1998 (baseline)unclearKivimaki 2015 - COPSOQ-I 19971803876DenmarkNationalNot reportedNot reportedMean age 40.6 years at baselineProspective cohort study1997 (baseline)unclearKivimaki 2015 - HeSSup 199816,1508971FinlandNationalNot reportedNot reportedMean age 39.6 years at baselineProspective cohort study1998 (baseline)unclearKivimaki 2015 - FPS 200044,56535,840FinlandNationalNot reportedNot reportedMean age 44.6 years at baselineProspective cohort study2000 (baseline)unclearKivimaki 2015 - HNR 20001774732GermanyRegionNot reportedNot reportedMean age 53.3 years at baselineProspective cohort study2000 (baseline)unclearKivimaki 2015 - DWECS 200055352590DenmarkNationalNot reportedNot reportedMean age 41.8 years at baselineProspective cohort study2000 (baseline)unclearKivimaki 2015 - COPSOQ-II 200433891785DenmarkNationalNot reportedNot reportedMean age 42.7 years at baselineProspective cohort study2004 (baseline)unclearKivimaki 2015 - IPAW 199620211360DenmarkRegionNot reportedNot reportedMean age 41.2 years at baselineProspective cohort study1996--1997 (baseline)unclearKivimaki 2015 - PUMA 199917831473DenmarkRegionNot reportedNot reportedMean age 42.7 years at baselineProspective cohort study1999 (baseline)unclearKivimaki 2015 - NWCS 200543,51022,178NetherlandsNationalNot reportedNot reportedMean age 40.1 years at baselineProspective cohort study2005--2006 (baseline)unclearKivimaki 2015 - Alameda 19731585666United StatesRegionNot reportedNot reportedMean age 44.4 years at baselineProspective cohort study1973 (baseline) to 199420 yearsKivimaki 2015 - NHANES I 198248752800United StatesNationalNot reportedNot reportedMean age 48.8 years at baselineProspective cohort study1982 (baseline) to 199210 yearsKivimaki 2015 - ACL 19861502802United StatesNationalNot reportedNot reportedMean age 44.5 years at baselineProspective cohort study1986 (baseline) to 200216 yearsKivimaki 2015 - WLSG 199254212883United StatesRegionNot reportedNot reportedMean age 54.1 years at baselineProspective cohort study1992 (baseline) to 2003--200510 yearsKivimaki 2015 - WLSS 199323661299United StatesRegionNot reportedNot reportedMean age 52.4 years at baselineProspective cohort study1993 (baseline) to 2004--200712 yearsKivimaki 2015 - MIDUS 199533031637United StatesNationalNot reportedNot reportedMean age 44.2 years at baselineProspective cohort study1995 (baseline) to 200510 yearsKivimaki 2015 - HILDA 200348792343AustraliaNationalNot reportedNot reportedMean age 41.4 years at baselineProspective cohort study2003 (baseline) to 20074 years[@b0120]145,86168,583DenmarkNationalNot reportedNot reported15--75 years at baselineProspective cohort study1999 (baseline) to 2013average 7.7 yearsHayashi 201915,2770JapanregionNot reportedNot reported40--59 years at baseline (means 48.1 to 51.2)Prospective cohort study1993 (baseline) to201220 years*Part II: exposure assessment and comparator*StudyExposure assessmentComparatorStudy IDExposure definition (i.e., how was the exposure defined?)Unit for which exposure was assessedMode of exposure data collectionExposure assessment methodsLevels/intensity of exposure (specify unit)Number of study participants in exposed groupNumber of study participants in unexposed groupDefinition of comparator (define comparator group, including specific level of exposure)Virtanen 2012 - Russek 1958engaged jobs other than main occupation or working 60 h or more per weekIndividual levelFace-to-face surveySelf-report50 and below hours/week, 51 and more hours/weekNot reportedNot reportedNon-occupational stress OR worked\<60 h per week OR worked\<60 h per week and non-contemporary day and evening work.Virtanen 2012 - [@b0450]overtime work more than the Swedish standardIndividual levelPen-and-paper surveySelf-reportovertime workNot reportedNot reportednon-overtime workVirtanen 2012 - [@b0455]average working hours per weekIndividual levelFace-to-face surveySelf-report50 and below hours/week, 51 and more hours/weekNot reportedNot reported50 and below hours/weekVirtanen 2012 - [@b0080]prolonged overtimeIndividual levelFace-to-face surveySelf-reportovertime workNot reportedNot reportedno overtime workVirtanen 2012 - [@b0410]Mean daily working hours≥11.01Individual levelPen-and-paper surveySelf-report≤7h/d, 7.01--9h/d, 9.01--11*h*/d, ≥11*h*/dNot reportedNot reported7.01--9h/dVirtanen 2012 - [@b0265]Weekly working hours\>61 was defined as overtime work.Individual levelFace-to-face surveySelf-report≤ 40 h/week, 41--60 h/week, ≥61 h/weekNot reportedNot reported≤ 40 h/weekVirtanen 2012 - Fukuoka 2005working hours per weekIndividual levelFace-to-face surveySelf-report≤ 40 h/week, 41--49 h/week, 50--54 h/week, ≥55 h/weekNot reportedNot reported≤ 40 h/weekJeong 2013working hours per weekIndividual levelUnclearSelf-report≤ 40 h/week, 40.1--48 h/week, 49--52 h/week, \> 52 h/weekNot reportedNot reported≤ 40 h/week[@b0040]working hours duration per day during the week prior to their disease onset (case)\
\
the same information during the week prior to the survey (control)Individual levelUnclearSelf-report\<40 h/week, 40--48 h/week, 49--60 h/week, \> 60 h/weekNot reportedNot reported40 to ≤48 h/week[@b0270]Working hours per weekIndividual levelFace-to-face surveySelf-reportnone, \<35 h/week, 35--40 h/week, 41--48 h/week, 49--54 h/week, and 55 h/weekNot reportedNot reportedWorktime: none[@b0285]Average hours worked per weekIndividual levelComputer-administered surveySelf-report\< 40 h/week, = 40 h/week, 41--50 h/week, \> 50 h/weekNot reportedNot reported\< 40 h/weekKivimaki 2015 - [@b0480]overtime work per dayIndividual levelPen-and-paper surveySelf-reportNo overtime, daily 1h overtime, 2h overtime, 3-4h overtime)27583256no overtime work (7--8 working h/d)Kivimaki 2015 - [@b0330]Weekly working hoursIndividual levelPen-and-paper surveySelf-report\<30 h/week, 30--37 h/week, 38--49 h/week, ≥50 h/week1034112\< 30 h/weekKivimaki 2015 - Holtermann 2010Weekly work hoursIndividual levelPen-and-paper surveySelf-report≤ 40 h/week, 41--45 h/week, ≥46 h/week4326638≤ 40 h/weekKivimaki 2015 - [@b0460]number of hours of work per dayIndividual levelPen-and-paper surveySelf-reportContinuous variableNot reportedNot reported7--8 h/weekKivimaki 2015 - O\'Reilly 2013hours per week (55 and over)Individual levelPen-and-paper surveySelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week39,069375,88035--40 h/weekKivimaki 2015 - WOLF-S 1992weekly working hoursIndividual levelUnclearSelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week232532235--40 h/weekKivimaki 2015 - Belstress 1994weekly working hoursIndividual levelUnclearSelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week72310,96235--40 h/weekKivimaki 2015 - WOLF-N 1996weekly working hoursIndividual levelUnclearSelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week55459335--40 h/weekKivimaki 2015 - COPSOQ-I 1997weekly working hoursIndividual levelUnclearSelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week109169435--40 h/weekKivimaki 2015 - HeSSup 1998weekly working hoursIndividual levelUnclearSelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week141714,73335--40 h/weekKivimaki 2015 - FPS 2000weekly working hoursIndividual levelUnclearSelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week141443,15135--40 h/weekKivimaki 2015 - HNR 2000weekly working hoursIndividual levelUnclearSelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week295147935--40 h/weekKivimaki 2015 - DWECS 2000weekly working hoursIndividual levelUnclearSelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week440509535--40 h/weekKivimaki 2015 - COPSOQ-II 2004weekly working hoursIndividual levelUnclearSelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week177321235--40 h/weekKivimaki 2015 - IPAW 1996weekly working hoursIndividual levelUnclearSelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week6201535--40 h/weekKivimaki 2015 - PUMA 1999weekly working hoursIndividual levelUnclearSelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week17176635--40 h/weekKivimaki 2015 - NWCS 2005weekly working hoursIndividual levelUnclearSelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week289340,61735--40 h/weekKivimaki 2015 - Alameda 1973weekly working hoursIndividual levelUnclearSelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week152143335--40 h/weekKivimaki 2015 - NHANES I 1982weekly working hoursIndividual levelUnclearSelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week477439835--40 h/weekKivimaki 2015 - ACL 1986weekly working hoursIndividual levelUnclearSelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week181132135--40 h/weekKivimaki 2015 - WLSG 1992weekly working hoursIndividual levelUnclearSelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week724469735--40 h/weekKivimaki 2015 - WLSS 1993weekly working hoursIndividual levelUnclearSelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week324204235--40 h/weekKivimaki 2015 - MIDUS 1995weekly working hoursIndividual levelUnclearSelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week464289335--40 h/weekKivimaki 2015 - HILDA 2003weekly working hoursIndividual levelUnclearSelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week541433835--40 h/week[@b0120]Weekly working hoursIndividual levelFace-to-face surveySelf-report35--40 h/week, 41--48 h/week, 49--54 h/week, ≥55 h/week23,143112,59335--40 h/weekHayashi 2019Working hours by dayIndividual levelsurveySelf-report\<7h/d; 7 to \<9h/d; 9 to \<11*h*/d; ≥11*h*/d798765967 to \<9h/dPart III: outcome assessment and statistical modellingStudyOutcome assessmentStatistical modellingStudy IDDefinition of outcomeWhich International Classification of Diseases (ICD) code was reported for the outcome (if any)?Diagnostic assessment methodNumber of cases with outcome of interest in exposed groupNumber of non-cases (i.e. without outcome of interest) in exposed groupNumber of cases with outcome of interest in unexposed groupNumber of non-cases (i.e. without outcome of interest) in unexposed groupAdjusted for confounding by: ageAdjusted for confounding by: sexAdjusted for confounding by: SESOther potential confounders adjusted forAdjusted for any mediationTreatment effect measure typeVirtanen 2012 - Russek 1958Coronary Heart Disease (myocardial infarction or typical angina of effort)Not reportedPhysician diagnostic recordN/A because of study designN/A because of study designN/A because of study designN/A because of study designNoYesYesUnclearNoORVirtanen 2012 - [@b0450]Non-fatal myocardial infarctionNot reportedHospital discharge recordN/A because of study designN/A because of study designN/A because of study designN/A because of study designNoNoNoUnclearNoORVirtanen 2012 - [@b0455]Acute myocardial infarctionNot reportedPhysician diagnostic recordN/A because of study designN/A because of study designN/A because of study designN/A because of study designNoNoUnclearUnclearNoORVirtanen 2012 - Falger 1992Acute myocardial infarctionNot reportedHospital admission recordN/A because of study designN/A because of study designN/A because of study designN/A because of study designYesNoYesYesNoORVirtanen 2012 - [@b0410]Acute myocardial infarctionNot reportedPhysician diagnostic recordN/A because of study designN/A because of study designN/A because of study designN/A because of study designYesNoYesYesNoORVirtanen 2012 - [@b0265]Non-fatal acute myocardial infarctionNot reportedHospital admission recordN/A because of study designN/A because of study designN/A because of study designN/A because of study designYesNoUnclearYesNoORVirtanen 2012 - Fukuoka 2005Acute myocardial infarctionNot reportedHospital admission recordN/A because of study designN/A because of study designN/A because of study designN/A because of study designYesNoNoUnclearUnclearORJeong 2013Non-fatal acute myocardial infarctionICD-10 121Hospital admission recordN/A because of study designN/A because of study designN/A because of study designN/A because of study designYesYesYesYesNoOR[@b0040]Acute myocardial infarction or severe coronary heart diseaseNot reportedHospital admission recordN/A because of study designN/A because of study designN/A because of study designN/A because of study designYesNoYesYesNoOR[@b0270]Coronary heart diseaseNot reportedHospital admission recordN/A because of study designN/A because of study designN/A because of study designN/A because of study designYesYesYesYesNoOR[@b0285]Ischaemic heart diseaseICD-9 410--414, 416Healthcare recordN/A because of study designN/A because of study designN/A because of study designN/A because of study designNoNoUnclearYesNoORKivimaki 2015 - [@b0480]Coronary heart diseaseICD-9 410--414 or ICD-10 I20-I25Hospital admission or death record18025781893067YesYesYesYesNoHazard ratioKivimaki 2015 - [@b0330]Ischaemic heart diseaseICD-8 410--414, ICD-10 I20-I25Hospital admission or death recordNot reportedNot reportedNot reportedNot reportedNoN/AN/AUnclearYesORKivimaki 2015 - Holtermann 2010Ischaemic heart disease mortalityICD-8 410--414, ICD-10 I20-I25Death record537378954584YesYesYesYesNoHazard ratioKivimaki 2015 - [@b0460]Ischaemic heart diseaseICD-9 410--414, ICD-10 I21-I25Hospital admission or death recordNot reportedNot reportedNot reportedNot reportedYesYesYesYesNoHazard ratioKivimaki 2015 - O\'Reilly 2013Ischaemic heart diseaseICD-10 I20-I25Death recordNot reportedNot reportedNot reportedNot reportedUnclearUnclearUnclearUnclearUnclearHazard ratioKivimaki 2015 - WOLF-S 1992Coronary Heart DiseaseICD-9 410--414, ICD-10 I21-I25Hospital admission or death recordNot reportedNot reportedNot reportedNot reportedYesYesYesNoNoHazard ratioKivimaki 2015 - Belstress 1994Coronary Heart DiseaseICD-9 410--414, ICD-10 I21-I25Hospital admission or death recordNot reportedNot reportedNot reportedNot reportedYesYesYesNoNoHazard ratioKivimaki 2015 - WOLF-N 1996Coronary Heart DiseaseICD-9 410--414, ICD-10 I21-I25Hospital admission or death recordNot reportedNot reportedNot reportedNot reportedYesYesYesNoNoHazard ratioKivimaki 2015 - COPSOQ-I 1997Coronary Heart DiseaseICD-9 410--414, ICD-10 I21-I25Hospital admission or death recordNot reportedNot reportedNot reportedNot reportedYesYesYesNoNoHazard ratioKivimaki 2015 - HeSSup 1998Coronary Heart DiseaseICD-9 410--414, ICD-10 I21-I25Hospital admission or death recordNot reportedNot reportedNot reportedNot reportedYesYesYesNoNoHazard ratioKivimaki 2015 - FPS 2000Coronary Heart DiseaseICD-9 410--414, ICD-10 I21-I25Hospital admission or death recordNot reportedNot reportedNot reportedNot reportedYesYesYesNoNoHazard ratioKivimaki 2015 - HNR 2000Coronary Heart DiseaseICD-9 410--414, ICD-10 I21-I25Hospital admission or death recordNot reportedNot reportedNot reportedNot reportedYesYesYesNoNoHazard ratioKivimaki 2015 - DWECS 2000Coronary Heart DiseaseICD-9 410--414, ICD-10 I21-I25Hospital admission or death recordNot reportedNot reportedNot reportedNot reportedYesYesYesNoNoHazard ratioKivimaki 2015 - COPSOQ-II 2004Coronary Heart DiseaseICD-9 410--414, ICD-10 I21-I25Hospital admission or death recordNot reportedNot reportedNot reportedNot reportedYesYesYesNoNoHazard ratioKivimaki 2015 - IPAW 1996Coronary Heart DiseaseICD-9 410--414, ICD-10 I21-I25Hospital admission or death recordNot reportedNot reportedNot reportedNot reportedYesYesYesNoNoHazard ratioKivimaki 2015 - PUMA 1999Coronary Heart DiseaseICD-9 410--414, ICD-10 I21-I25Hospital admission or death recordNot reportedNot reportedNot reportedNot reportedYesYesYesNoNoHazard ratioKivimaki 2015 - NWCS 2005Coronary Heart DiseaseICD-9 410--414, ICD-10 I21-I25Hospital admission or death recordNot reportedNot reportedNot reportedNot reportedYesYesYesNoNoHazard ratioKivimaki 2015 - Alameda 1973Coronary Heart DiseaseNot reportedSelf-reportNot reportedNot reportedNot reportedNot reportedYesYesYesNoNoORKivimaki 2015 - NHANES I 1982Coronary Heart DiseaseNot reportedSelf-reportNot reportedNot reportedNot reportedNot reportedYesYesYesNoNoORKivimaki 2015 - ACL 1986Coronary Heart DiseaseNot reportedSelf-reportNot reportedNot reportedNot reportedNot reportedYesYesYesNoNoORKivimaki 2015 - WLSG 1992Coronary Heart DiseaseNot reportedSelf-reportNot reportedNot reportedNot reportedNot reportedYesYesYesNoNoORKivimaki 2015 - WLSS 1993Coronary Heart DiseaseNot reportedSelf-reportNot reportedNot reportedNot reportedNot reportedYesYesYesNoNoORKivimaki 2015 - MIDUS 1995Coronary Heart DiseaseNot reportedSelf-reportNot reportedNot reportedNot reportedNot reportedYesYesYesNoNoORKivimaki 2015 - HILDA 2003Coronary Heart DiseaseNot reportedSelf-reportNot reportedNot reportedNot reportedNot reportedYesYesYesNoNoOR[@b0120]Ischaemic heart diseaseICD-10 I20-I25Hospital admission or death record66422,4792779109,814YesYesYesYesNoHazard ratioHayashi 2019Acute myocardial infarctionNot reportedHospital admission or death record867801766520YesNoYesYesYesHazard ratio

### 4.2.1. Study type {#s0165}

Most studies were cohort studies (26 studies), followed by case-control studies (11). The type of effect estimates most commonly reported were ORs (19 studies) and hazard ratios (18 studies). All included studies were adjusted for our three pre-specified minimum confounders. However, several case-control studies in additional also adjusted for further potential confounders ([Table 5](#t0025){ref-type="table"}).

### 4.2.2. Population studied {#s0170}

The included studies captured 768,751 workers (310,954 females and 457,797 males). The studies were of females only, males only, or both female and male workers. The most commonly studied age groups were those between 20 and 65 years.

By WHO region, most studies examined populations in the European region (20 studies from eight countries), followed by populations in the Americas (nine studies from one country) and populations in the Western Pacific (eight studies from four countries). The most commonly studied countries were the United States (nine studies), Denmark (eight), Japan (four) and Sweden (three). Most studies did not provide quantitative break downs of participants by industrial sectors and occupation, but they did appear to cover several industrial sectors and occupations.

### 4.2.3. Exposure studied {#s0175}

All studies measured exposure to long working hours with either self-reported questionnaire or face-to-face interview. Other measures such as official or company records of hours worked were not used.

### 4.2.4. Comparator studied {#s0180}

The comparator for most studies was 35--40 h/week. One of the 26 cohort studies ([@b0130]) used a comparator of 7 to \<9 h/day, which we judged to be comparable to 35--40 h/week. Nine out of 11 case-control studies used slightly different comparators ([@b0485] -- [@b0385], [@b0485] - [@b0450], [@b0485] - [@b0455], [@b0485] -- [@b0080], [@b0485] -- [@b0410], [@b0485] - [@b0265], [@b0040], [@b0270], [@b0285]).

### 4.2.5. Outcomes studied {#s0185}

No studies reported evidence on the outcome of IHD prevalence.

Thirty-five studies (24 cohort studies and 11 case-control studies) reported evidence on the outcome "Acquired IHD" (or IHD incidence). Of these, 19 studies (8 cohort studies and 11 case-control studies) defined the outcome as incidence of a non-fatal IHD event, and 16 studies (all cohort studies) as an incident IHD event that was either non-fatal or fatal ("mixed").

Eighteen studies (all cohort studies) reported evidence on the outcome "Died from IHD" (or IHD mortality). Two of these studies defined the outcome as a fatal IHD event, and the remaining 16 studies used a "mixed" outcome definition including both fatal and/or non-fatal IHD events.

Outcome assessment was by administrative health records in 30 studies and self-reported physician diagnosis in seven studies (Appendix 4 in the [Supplementary data](#s0505){ref-type="sec"} for questions).

4.3. Risk of bias at individual study level {#s0190}
-------------------------------------------

### 4.3.1. Acquired IHD (IHD incidence) {#s0195}

The risk of bias rating for each domain for all 35 included studies for this outcome are presented in [Fig. 3](#f0015){ref-type="fig"}. The justification for each rating for each domain by included study is presented in Appendix 5 in the [Supplementary data](#s0505){ref-type="sec"}. We prioritized the evidence from the 24 cohort studies included in our systematic review for this outcome as the main evidence for the outcome, because we judged evidence from these studies to carry relatively less risk of bias, and we deprioritized the evidence from case-control studies as supporting evidence. Therefore, for assessing the quality of evidence for this outcome (see [Section 4.6](#s0360){ref-type="sec"}. Quality of evidence), we assessed the risk of bias in the body of evidence for this outcome based on risk of bias in the prioritized studies (cohort studies) only, rather than in the entire or supporting evidence.Fig. 3Summary of risk of bias, Acquired ischaemic heart disease (IHD incidence). Footnotes: \* Case-control study (supporting evidence).

#### 4.3.1.1. Selection bias {#s0200}

We assessed risk of bias in this domain based on whether the groups being compared were the same in all relevant ways (or as close to this as possible) apart from the exposure. Of the 24 included cohort studies, the risk of selection bias was rated to be probably high for one study due to unavailability of follow-up data in one region out of six regions and male workers only ([@b0130]). However, we are aware that unavailability of one region does not necessarily suggest increased risk of selection bias as the same exposure-outcome effect can be expected. We rated the risk of selection bias as probably high for seven studies because these studies included only a specific subpopulation or selected industrial sector and reported only a low study participation rate (Kivimaki 2015 - [@b0480], Kivimaki 2015 - COPSOQ-I 1997, Kivimaki 2015 - HeSSup 1998, Kivimaki 2015 - FPS 2000, Kivimaki 2015 - COPSOQ-II 2004, Kivimaki 2015 - IPAW 1996, Kivimaki 2015 - ACL 1986). The risk of this bias in the other 16 studies was rated as probably low, because these studies provided indirect evidence that captured large, probably representative populations; these studies described their sample criteria extensively, enabling comparisons with the source population, while at the same time providing indirect evidence on acceptable inclusion criteria, recruitment and enrolment procedures, and participation rates ([Fig. 3](#f0015){ref-type="fig"}).

For case-control studies, the risk of selection bias was rated high in one study, probably high in nine studies, and probably low in one study (Appendix 5 in the [Supplementary data](#s0505){ref-type="sec"} for ratings given by included study). Unlike cohort studies, most case-control studies due to their high selection bias did not adequately represent the source population (Appendix 5 for justification for the ratings for each included study).

#### 4.3.1.2. Performance bias {#s0205}

For the included cohort studies, blinding of study participants and study personnel to assignments of study participants to exposure to long working hour and to study participants' characteristics was usually not reported in the study's record or records. There is a likely minor and negligible risk of bias that knowledge of such exposure assignment and/or study participants' characteristics could have impacted the reporting and/or analysis of the estimated impact of the exposure on the outcome. The outcome is mostly measured using administrative data, and this further reduced our concerns for risk of detection bias for the outcome. Therefore, we rated all studies as probably low risk ([Fig. 3](#f0015){ref-type="fig"}; Appendix 5 in the [Supplementary data](#s0505){ref-type="sec"}).

For case-control studies, the risk of performance bias was rated as probably low in all studies. Although study participants and study personnel were blinded to neither exposure assignment, nor study participants' characteristics, it is unlikely that this lack of blinding impacted analysis and reporting of exposure-outcome associations.

#### 4.3.1.3. Detection bias (exposure assessment) {#s0210}

For cohort studies, although an objective assessment of the exposure would have reduced the risk of detection bias for the exposure assessment, we judged the uniform standard self-report assessment of exposure to not have introduced noteworthy risk of detection bias. Self-report of (long) working hours has been validated against objective measures of long working hours (e.g., [@b0155]), and, in our opinion, it is therefore unlikely that use of self-reported exposure in the included studies introduced any substantial detection bias. We consequently rated all studies as carrying probably low risk of detection bias in the exposure assessment.

For case-control studies, we rated risk of performance bias as probably low in all studies. We again judged that self-report of (long) working hours was unlikely to have introduced any substantial risk of detection bias, since such subjective measures have been validated against objective measures of long working hours (e.g., [@b0155]).

#### 4.3.1.4. Detection bias (outcome assessment) {#s0215}

For the included cohort studies, the 16 studies with a "mixed" outcome definition that comprised both fatal and non-fatal IHD events used administrative data, namely either physician-based clinical diagnoses or ICD-coded records. Therefore, we rated risk of detection bias for these studies as low. However, seven studies used self-report outcome data. There is some evidence that self-reported diagnoses of IHD events are valid measurements ([@b0310]). However, we rated the risk of detection bias in these studies (Kivimaki 2015 - ACL 1986, Kivimaki 2015 - Alameda 1973, Kivimaki 2015 - HILDA 2003, Kivimaki 2015 - MIDUS 1995, Kivimaki 2015 - WLSG 1992, Kivimaki 2015 - WLSS 1993) as either probably high or high, because the wording used in the survey questions to assess the outcome was unspecific (see Appendix 4 in the [Supplementary data](#s0505){ref-type="sec"}). We considered whether inclusion of recurrent IHD events might have produced any misclassification bias of the outcome, but did not find any study that reported data on both first and recurrent IHD events that would allow evaluation of any potential risk of such bias.

For case-control studies, all studies were rated as low risk of detection bias, because the outcome assessment had a high accuracy, given appropriate quality of assessment methods (clinical diagnosis of IHD patients).

#### 4.3.1.5. Confounding {#s0220}

Of the 24 cohort studies included in the systematic review for this outcome, 23 studies:•appropriately adjusted or controlled for all (or at least most) of our three pre-specified potential confounders that studies should adjust or control for (i.e., age, sex, and socioeconomic position);•if they additionally controlled their effect estimates for further variables that could be confounders, mediators and/or moderators and/or reported that they adjusted or controlled for additional such variables, but found that these adjustments or controls did not affect the effect estimates, then we judged these additional adjustments to not carry risk of confounding; and•used appropriate statistical techniques for confounder adjustment and/or control, with the exception of one study which did not apply the requested statistical approaches for adjustment of confounding factors (Kivimaki 2015 - [@b0460]).

Overall, we consequently judged these 23 studies to have probably low risk of confounding.

One study (Kivimaki 2015 - [@b0460]) potentially over-adjusted for working hours and burnout, and we therefore judged this study to have probably high risk of confounding.

Of the seven case-control studies, we rated one study as having high risk, five studies as having probably high risk, and one as having probably low risk of confounding. Our ratings of high risk of confounding were justified by a total lack of adjustment and/or control for the three pre-specified potential confounders. Our ratings of probably high risk of confounding were justified by insufficient such confounder adjustment/control.

#### 4.3.1.6. Selection bias (incomplete outcome data) {#s0225}

We judged that in all 24 cohort studies included for this outcome:•the proportion of invited persons who participated in the study was acceptably high;•the proportion of study participants who were lost to follow-up over time was acceptably low;•the study followed up study participants sufficiently long after exposure to long working hours for them to reasonably have acquired the outcome;•the proportion of outcome data that was missing at baseline was acceptably low;•the proportion of outcome data missing at final follow up was acceptably low (i.e., \<50%);•there was balance across exposure groups in the survey non-response at baseline, item non-response at baseline, missing participants at final follow up and missing outcome data at final follow-up, with similar reasons for missing study participants and/or outcome data across groups (if reported); and/or•the missing outcome data were imputed using appropriate statistical methods.

Based on these considerations, we judged all the cohort studies to have low risk of selection bias due to incomplete outcome data.

For all case-control studies, outcome data were complete, with no outcome data missing from any study participant. Given the case-control design, risk of selection bias due to incomplete outcome data was unlikely as no study participants were lost during follow-up. We are aware that a potential risk of selection bias due to incomplete outcome data may be due to differential item non-responses, but respective information was not available from published studies and was judged as unlikely. We therefore rated these studies as having a low risk of bias in this domain.

#### 4.3.1.7. Reporting bias {#s0230}

In all cohort studies with pre-published protocols the outcomes were reported in the included study record as they had been pre-specified in the protocol. In the cohort studies without a pre-published protocol, the outcomes were reported in the results sections of the study records as they had been reported in the abstracts and methods sections in the study record. We also did not find any other evidence that reporting may have been biased. We consequently judged risk of reporting bias as low in all included cohort studies.

For case-control studies, reporting bias is unlikely as all of the study's pre-specified outcomes outlined in the pre-published protocol or the published manuscript have been reported in the pre-specified way. Therefore, all studies were rated as low risk of this bias.

#### 4.3.1.8. Conflict of interest {#s0235}

All cohort studies included for this outcome:•did not receive support from a company or other entity with a financial interest in the study findings;•were funded by public research agencies or related organizations that were free from commercial interests in the study findings;•were authored only by persons who were not affiliated with companies or other entities with vested interests; and/or;•had no conflict of interest declared by study authors.

Therefore, we rated all studies as having low risk of bias from conflict of interest.

Similarly, we judged all case-control studies to have low bias in this domain, because these studies were also conducted exclusively by researchers that were publicly funded, and we also again found no evidence of commercial interests influencing these studies.

#### 4.3.1.9. Other risk of bias {#s0240}

We did not find any evidence for any risk of other types of bias in any included cohort or case-control study and therefore judged all included cohort and case-control studies to have a low risk of other bias.

### 4.3.2. Died from IHD (IHD mortality) {#s0245}

The risk of bias rating for each domain for all 18 included studies for this outcome are presented in [Fig. 4](#f0020){ref-type="fig"}, and our detailed justifications for each rating for each domain are again shown in Appendix 5 in the [Supplementary data](#s0505){ref-type="sec"}.Fig. 4Summary of risk of bias, Died from ischaemic heart disease (IHD mortality).

#### 4.3.2.1. Selection bias {#s0250}

For the 18 cohort studies, this bias was rated probably high for one study, due to unavailability of follow-up data in one region out of six regions, and male workers only ([@b0130]). In addition, six studies were rated as probably high because of only a specific population or industry being included and, and low study participation rate (Kivimaki 2015 - [@b0480], Kivimaki 2015 - COPSOQ-I 1997, Kivimaki 2015 - HeSSup 1998, Kivimaki 2015 - FPS 2000, Kivimaki 2015 - COPSOQ-II 2004, Kivimaki 2015 - IPAW 1996). This bias was rated as probably low for the other 11 studies because these studies comprised large populations of working age and described their sample criteria extensively, enabling comparisons with the source population, while at the same time providing indirect evidence only on inclusion criteria, recruitment and enrolment procedures, and participation rates ([Fig. 4](#f0020){ref-type="fig"}).

#### 4.3.2.2. Performance bias {#s0255}

For the included cohort studies, blinding of study participants and study personnel to assignments of study participants to exposure to long working hours and to study participants' characteristics was usually not reported in the study's record or records. There is a likely minor and negligible risk of bias that knowledge of such exposure assignment and/or study participants' characteristics could have impacted the reporting and/or analysis of the estimated impact of the exposure on the outcome. The outcome is mostly measured using administrative data, and this further reduced our concerns for risk of detection bias for the outcome. Therefore, we rated all studies as probably low risk of performance bias ([Fig. 4](#f0020){ref-type="fig"}).

#### 4.3.2.3. Detection bias (exposure assessment) {#s0260}

Although an objective assessment of the exposure would have reduced the risk of detection bias for the exposure assessment, we judged the uniform standard self-report assessment of exposure to not have introduced noteworthy risk of detection bias. Self-report of (long) working hours has been validated against objective measures of long working hours (e.g., [@b0155]), and in our opinion it is therefore unlikely that use of self-reported exposure in the included studies introduced any substantial detection bias. We consequently rated all studies as probably low risk of detection bias in the exposure assessment.

#### 4.3.2.4. Detection bias (outcome assessment) {#s0265}

All studies with a "mixed" outcome definition that comprised both fatal and non-fatal IHD events used administrative data, namely either physician-based clinical diagnoses or ICD-coded records. Two studies used the death register data with specific ICD codes that were very accurate. Therefore, we rated the risk of detection bias for all these studies as low.

#### 4.3.2.5. Confounding {#s0270}

Of the 18 cohort studies included in the systematic review for this outcome, 16 studies:•appropriately adjusted or control for all (or at least most) of our three-ore-specified potential confounders that studies should adjust or control for (i.e., age, sex, and socioeconomic position).•if they additionally controlled their effect estimates for further variables that could be confounders, mediators and/or moderators and/or reported that they adjusted or controlled for additional such variables, but found that these adjustments or controls did not affect the effect estimates, then we judged these additional adjustments to not carry risk of confounding; and•used appropriate statistical techniques for confounder adjustment and/or control.

Overall, we consequently judged these 16 studies to have probably low risk of confounding. Two studies (Kivimaki 2015 - O\'Reilly 2013, Kivimaki 2015 - [@b0480]) with comprehensive statistical techniques for confounder adjustment and/or control were rated as low risk of confounding.

#### 4.3.2.6. Selection bias (incomplete outcome data) {#s0275}

We judged that in all 18 cohort studies included for this outcome:•the proportion of invited persons who participated in the study was acceptably high;•the proportion of study participants who were lost to follow-up over time was acceptably low;•the study followed up study participants sufficiently long after exposure to long working hours for them to reasonably have acquired the outcome;•the proportion of outcome data that was missing at baseline was acceptably low;•the proportion of outcome data missing at final follow up was acceptably low (i.e. \<50%);•there was balance across exposure groups in the survey non-response at baseline, item non-response at baseline, missing participants at final follow up and missing outcome data at final follow-up, with similar reasons for missing study participants and/or outcome data across groups (if reported); and/or•the missing outcome data were imputed using appropriate statistical methods.

Based on these considerations, we judged all the studies to have low risk of selection bias due to incomplete outcome data.

#### 4.3.2.7. Reporting bias {#s0280}

In all cohort studies with pre-published protocols the outcomes were reported in the included study record as they had been pre-specified in the protocol. In the cohort studies without a pre-published protocol, the outcomes were reported in the results sections of the study records as they had been reported in the abstracts and methods sections in the study record, and we also did not find any other evidence that reporting may have been biased. We consequently judged risk of reporting bias as low in all included cohort studies.

#### 4.3.2.8. Conflict of interest {#s0285}

All cohort studies included for this outcome:•did not receive support from a company or other entity with a financial interest in the study findings;•were funded by public research agencies or related organizations that were free from commercial interests in the study findings;•were authored only by persons who were not affiliated with companies or other entities with vested interests; and/or•had no conflict of interest declared by study authors.

Therefore, we judged all studies as having low risk of bias from conflict of interest.

#### 4.3.2.9. Other risk of bias {#s0290}

We did not find any evidence for any risk of other types of bias in any included cohort studies and therefore judged all included cohort studies to have a low risk of other bias.

4.4. Synthesis of results {#s0295}
-------------------------

### 4.4.1. Outcome: Has IHD (IHD prevalence) {#s0300}

No eligible study was found on the effect of long working hours on IHD prevalence.

### 4.4.2. Outcome: Acquired IHD (IHD incidence) {#s0305}

#### 4.4.2.1. Comparison: Worked 41--48 h/week compared with worked 35--40 h/week {#s0310}

A total of 27 studies (20 cohort studies and seven case-control studies) with a total of 315,723 participants reported data on this comparison for this outcome. We meta-analysed evidence from cohort studies separately from that from case-control studies. In our risk of bias assessment for the outcome ([Section 4.3.1](#s0195){ref-type="sec"}), we judged cohort studies to carry a relatively lower risk of bias than case-control studies and consequently prioritize evidence from cohort studies over that from case-control studies. Our main meta-analysis for this comparison for this outcome is consequently that of the included cohort studies.

Twenty cohort studies with a total of 312,209 participants from three WHO regions reported estimates of the effect of exposure to long working hours on the risk of acquiring IHD when working 41--48 h/week, compared with 35--40 h/week. These studies were somewhat heterogeneous in that seven studies defined the outcome as a non-fatal IHD event (Alameda, NHANES I, ACL, WLSG, WLSS, MIDUS, and HILDA), whereas 13 of the studies defined the outcome as a non-fatal or fatal (or "mixed") IHD event ([@b0120], WOLF-S, Belstress, WOLF-N, COPSOQ-I, HeSSup, FPS, HNR, DWECS, COPSOQ-II, IPAW, PUMA, and NWCS). Because fatal and non-fatal IHD events share an identical pathophysiological basis we considered studies with pure non-fatal events and studies with both fatal and non-fatal ("mixed") events to be sufficiently homogenous clinically be included in the same meta-analysis. Moreover, subgrouping pure non-fatal and "mixed" event studies demonstrated no evidence for subgroup differences (Appendix 6 in the [Supplementary data](#s0505){ref-type="sec"}), suggesting that these studies are sufficiently homogenous statistically to be combined. Therefore, we judged the heterogeneity of the included studies to be sufficiently low overall, and we consequently combined all included studies in one meta-analysis. This has also been done in previous meta-analyses ([@b0200], [@b0495]). Compared with working 35--40 h/week, working 41--48 h/week led to a risk of about 1 of acquiring IHD (relative risk (RR) 0.98, 95% CI 0.91 to 1.07, 20 studies, 312,209 participants, I^2^ 0%; [Fig. 5](#f0025){ref-type="fig"}).Fig. 5Main meta-analysis of prioritized evidence (cohort studies), Outcome: Acquired ischaemic heart disease, Comparison: Worked 41--48 h/week compared with worked 35--40 h/week.

Of the seven case-control studies with eligible evidence including a total of 3514 participants, two studies provided evidence with the exact definition of the exposure and reference categories ([@b0100], [@b0175]). We considered these two studies to be sufficiently homogenous to be combined in a quantitative meta-analysis. Compared with working 35--40 h/week, working 41--48 h/week led to a reduction in risk of acquiring IHD (OR 0.26, 95% CI 0.13 to 0.49, 2 studies, 962 participants, I^2^ 0%; [Fig. 6](#f0030){ref-type="fig"}). Three case-control studies used similar comparisons ([@b0485] -- [@b0410], [@b0485] - [@b0265], [@b0285]). Compared with working ≤40 or \<45 h/week, there was an elevated OR with a lower confidence bound that crossed 1 that working 40--60 h/week (or a comparable number of hours) had any effect on the risk of acquiring IHD (OR 1.14, 95% CI 0.85 to 1.53, 3 studies, 1923 participants, I^2^ 0%; [Fig. 6](#f0030){ref-type="fig"}). Moreover, two studies conducted several decades ago compared any overtime work with no overtime work ([@b0485] -- [@b0080], [@b0485] - [@b0450]), indicating an increase in the risk of acquiring IHD (OR 1.97, 95% CI 1.30 to 3.00, 2 studies, 629 participants, I^2^ 12%; [Fig. 6](#f0030){ref-type="fig"}). When we combined the three subgroups defined by exposure categories in one meta-analysis, our test for subgroup differences found statistically significant differences, and we therefore turned the overall pooled effect estimate off and only report subtotals for each subgroup. In addition, two case-control studies were not included in any meta-analysis because they used different comparators. One of these studies reported that compared with working 40--48 h/week, working \<40 h/weeks increased the risk of acquiring IHD with the lower confidence bound crossing 1 (OR 1.5, 95% CI 0.9 to 2.3, 966 participants) ([@b0040]). The second study reported that compared with working zero hours/week, working 41--48 h/weeks increased the risk of acquiring IHD with the lower confidence bound crossing 1 (OR 1.44, 95% CI 0.76 to 2.73, 595 participants) ([@b0270]).Fig. 6Supporting meta-analysis of deprioritized evidence (case-control studies), Outcome: Acquired ischaemic heart disease, Comparison: Worked 41--48 h/week compared with worked 35--40 h/week (or similar comparisons, or any overtime work). Footnotes: The similar comparisons included in this meta-analysis were: [@b0285] h/w vs. \<40 h/w; Virtanen 2012 - [@b0265]: 41 to 60 h/w vs. ≤40 h/w; and Virtanen 2012 - [@b0410]: 9.01 to 11.00 h/d vs. 7.01 to 9.00 h/d.

#### 4.4.2.2. Comparison: Worked 49--54 h/week compared with worked 35--40 h/week {#s0315}

A total of 24 studies (18 cohort studies and six case-control studies) with a total of 311,227 participants reported data on this comparison for this outcome. We again meta-analysed evidence from cohort studies separately from that from case-control studies and prioritize evidence from cohort studies over that from case-control studies, for the reasons outline above ([Section 4.4.2.1](#s0310){ref-type="sec"}). Our main meta-analysis for this comparison for this outcome again is also that of the eligible cohort studies.

Eighteen cohort studies with a total of 308,405 participants from three WHO regions reported estimates of the effect of exposure to long working hours on the risk of acquiring IHD when working 49--54 h/week, compared with working 35--40 h/week. The included studies were again somewhat heterogeneous in outcome definition, with seven studies defining the outcome as a non-fatal IHD event (Alameda, NHANES I, ACL, WLSG, WLSS, MIDUS, and HILDA) and 11 studies defining the outcome as a non-fatal or fatal (or "mixed") IHD event ([@b0120], WOLF-S, Belstress, WOLF-N, COPSOQ-I, HeSSup, FPS, HNR, DWECS, COPSOQ-II, and NWCS). As with the previous comparison for the same outcome, we again judged these studies to be sufficiently homogenous clinically to potentially be combined, again also found no evidence for subgroup differences between studies defined by these outcome definitions (Appendix 6 in the [Supplementary data](#s0505){ref-type="sec"}), and therefore again decided to combine these studies in one meta-analysis, as has also been done previously ([@b0200], [@b0495]). Compared with working 35--40 h/week, working 49--54 h/week led to an elevated risk of acquiring IHD with the lower confidence bound being below 1 (RR 1.05, 95% CI 0.94 to 1.17, 18 studies, 308,405 participants, I^2^ 0%; [Fig. 7](#f0035){ref-type="fig"}).Fig. 7Main *meta*-analysis of prioritized evidence (cohort studies), Outcome: Acquired ischaemic heart disease, Comparison: Worked 49--54 h/week compared with worked 35--40 h/week.

Of the six case-control studies with eligible evidence including a total of 2,822 participants, two provided evidence with the exact definition of the exposure and reference categories ([@b0100], [@b0175]). We considered these studies to be sufficiently homogenous clinically to be combined in a quantitative meta-analysis. There was a reduction for effect of working 49--54 compared with 35--40 h/week on the risk of acquiring IHD (OR 0.23, 95% CI 0.09 to 0.59, 2 studies, 962 participants, I^2^ 0%; [Fig. 8](#f0040){ref-type="fig"}). Two case-control studies used similar comparisons ([@b0485] -- [@b0410], [@b0485] - [@b0265]). Compared with working ≤40 or \<45 h/week, there was an elevated risk with lower CI below 1 that working 41--60 h/week (or a comparable number of hours) had an effect on the risk of incident IHD (OR 1.15, 95% CI 0.84 to 1.59, 2 studies, 1231 participants, I^2^ 0%; [Fig. 8](#f0040){ref-type="fig"}). Moreover, two studies conducted several decades ago compared any overtime work with no overtime work ([@b0485] -- [@b0080], [@b0485] - [@b0450]), with our meta-analysis of these studies finding an increase in the risk of acquiring IHD (RR 1.97, 95% CI 1.30 to 3.00, 2 studies, 629 participants, I^2^ 12%; [Fig. 8](#f0040){ref-type="fig"}). As with the previous comparison ([Section 4.4.2.1](#s0310){ref-type="sec"}), when we combined the three subgroups defined by exposure categories in one meta-analysis, our test for subgroup differences again found statistically significant differences, and we therefore again turned the overall pooled effect estimate off and only report subtotals for each subgroup. In addition, two case-control studies were not included into meta-analysis because of different comparators: compared with working 40--48 h/week, those working 49--60 h/weeks had an increase in the risk of acquiring IHD (OR 1.6, 95% CI 1.2 to 2.2, 966 participants) ([@b0040]); compared with working zero hours/week, there was an elevated risk with the lower CI below 1 and the upper almost 3 that working 49--54 h/weeks had effect on the risk of acquiring IHD (OR 1.38, 95% CI 0.67 to 2.86, 595 participants) ([@b0270]).Fig. 8Supporting *meta*-analysis of deprioritized evidence (case-control studies), Outcome: Acquired ischaemic heart disease, Comparison: Worked 49--54 h/week compared with worked 35--40 h/week (or similar comparisons, or any overtime work). Footnotes: The similar comparisons included in the meta-analysis were: Virtanen 2012 - [@b0265]: 41 to 60 h/w vs. ≤40 h/w and Virtanen 2012 - [@b0410]: 9.01 to 11.00 h/d vs. 7.01 to 9.00 h/d.

#### 4.4.2.3. Comparison: Worked ≥55 h/week compared with worked 35--40 h/week {#s0320}

A total of 31 studies (22 cohort studies and nine case-control studies) with a total of 343,494 participants reported data on this comparison for this outcome. We again meta-analysed evidence from cohort studies separately from that from case-control studies; prioritized evidence from cohort studies over that from case-control studies; and use as our main meta-analysis that of the eligible cohort studies, for the reasons already detailed in [4.4.2.1](#s0310){ref-type="sec"}, [4.4.2.2](#s0315){ref-type="sec"}.

Twenty-two cohort studies with a total of 339,680 participants from three WHO regions reported estimates of the effect of exposure to long working hours on the risk of acquiring IHD when working ≥55 h/week, compared with working 35--40 h/week. All these studies could be included in a quantitative meta-analysis. These studies that we pooled in our meta-analysis were somewhat heterogeneous in that eight studies defined the outcome as a non-fatal IHD event (Alameda, NHANES I, ACL, WLSG, WLSS, MIDUS, HILDA, and [@b0460]), whereas 14 of the studies defined the outcome as a non-fatal or fatal (or "mixed") IHD event ([@b0330], [@b0480], [@b0120], Hayashi 2019¸WOLF-S, Belstress, WOLF-N, COPSOQ-I, HeSSup, FPS, HNR, DWECS, COPSOQ-II, NWCS). As with both previous comparisons for the same outcome, we again judged these studies to be sufficiently homogenous clinically to potentially be combined, again also found no evidence for subgroup differences between studies defined by these outcome definitions (Appendix 6 in the [Supplementary data](#s0505){ref-type="sec"}), and therefore again decided to combine these studies in one meta-analysis. In our meta-analysis, compared with working 35--40 h/week, working ≥55 h/week was associated with an elevated risk with lower CI above 1 of acquiring IHD (relative risk (RR) 1.13, 95% CI 1.02 to 1.26, 22 studies, 339,680 participants, I^2^ 5%; [Fig. 9](#f0045){ref-type="fig"}).Fig. 9Main meta-analysis of prioritized evidence (cohort studies), Outcome: Acquired ischaemic heart disease, Comparison: Worked ≥55 h/week compared with worked 35--40 h/week.

Of the nine case-control studies with eligible evidence including a total of 3814 participants, 2 provided evidence with the exact definition of the exposure and reference categories ([@b0100], [@b0175]). We considered these studies to be sufficiently homogenous with regard to the defined outcome criteria to be combined in a quantitative meta-analysis. There was no evidence for any effect of working ≥55 compared with 35--40 h/week on the risk of acquiring IHD (OR 0.74, 95% CI 0.41 to 1.34, 2 studies, 962 participants, I^2^ 0%; [Fig. 10](#f0050){ref-type="fig"}). Three case-control studies used similar comparisons ([@b0485] -- [@b0410], [@b0485] - [@b0265], [@b0285]). Compared with working ≤40 or \<45 h/week, working \>50 h/week (or a comparable number of hours) led to an increase in the risk of incident IHD with lower CI below 1 (OR 1.52, 95% CI 0.65 to 3.55, 3 studies, 1923 participants, I^2^ 71%; [Fig. 10](#f0050){ref-type="fig"}). Moreover, two studies conducted several decades ago compared any overtime work with no overtime work ([@b0485] -- [@b0080], [@b0485] - [@b0450]), finding an elevated risk of acquiring IHD by an estimated 97% (OR 1.97, 95% CI 1.30 to 3.00, 2 studies, 629 participants, I^2^ 12%; [Fig. 10](#f0050){ref-type="fig"}); two studies conducted several decades ago compared worked ≥51 h/w with worked \<51 h/w ([@b0485] - Russek, 1958, [@b0485] - Lthiel 1973), also finding an increase in the risk of acquiring IHD by an estimated 176% (OR 2.76, 95% CI 1.45 to 5.27, 2 studies, 300 participants, I^2^ 54%; [Fig. 10](#f0050){ref-type="fig"}). When we combined the four subgroups defined by exposure categories in one meta-analysis, our test for subgroup differences found statistically significant differences, and we therefore turned the overall pooled effect estimate off and only report subtotals for each subgroup. In addition, 2 case-control studies were not included into meta-analysis because of different comparators: compared with working 40--48 h/week, those working \>60 h/weeks had an increase in the risk of acquiring IHD (OR 2.2, 95% CI 1.6 to 3.1, 966 participants) ([@b0040]); compared with working zero hours/week, those working ≥55 h/weeks had an increase in the risk of acquiring IHD (OR 2.21, 95% CI 1.12 to 4.36, 595 participants) ([@b0270]).Fig. 10Supporting meta-analysis of deprioritized evidence (case-control studies), Outcome: Acquired ischaemic heart disease, Comparison: Worked ≥55 h/week compared with worked 35--40 h/week (or similar comparisons, or any overtime work). Footnotes: The similar comparisons included in this meta-analysis were: [@b0285]: \>50 h/w vs. \<40 h/w; Virtanen 2012 - [@b0265]: ≥61 h/w vs. ≤40 h/w; and Virtanen 2012 - [@b0410]: ≥11.01 h/d vs. 7.01 to 9.00 h/d.

### 4.4.3. Outcome: Died from IHD (IHD mortality) {#s0325}

#### 4.4.3.1. Comparison: Worked 41--48 h/week compared with worked 35--40 h/week {#s0330}

A total of 13 cohort studies with a total of 288,278 participants from one WHO region reported estimates of the effect of exposure to long working hours on the risk of dying from IHD when working 41--48 h/week, compared with 35--40 h/week. All these studies defined the outcome as a non-fatal or fatal (or "mixed") IHD event. All these studies could be included in a quantitative meta-analysis. We found that compared with working 35--40 h/week, working 41--48 h/week was associated with a near equal (1) risk of dying from IHD (RR 0.99, 95% CI 0.88 to 1.12, 13 studies, 288,278 participants, I^2^ 8%; [Fig. 11](#f0055){ref-type="fig"}).Fig. 11Main meta-analysis of cohort studies, Outcome: Died from ischaemic heart disease, Comparison: Worked 41--48 h/week compared with worked 35--40 h/week.

#### 4.4.3.2. Comparison: Worked 49--54 h/week compared with worked 35--40 h/week {#s0335}

A total of 11 cohort studies with a total of 284,474 participants from one WHO region reported estimates of the effect of exposure to long working hours on the risk of dying from IHD when working 49--54 h/week, compared with 35--40 h/week. Again, all these included studies defined the outcome as a non-fatal or fatal (or "mixed") IHD event, and we again judged these studies to be sufficiently homogenous clinically to be combined in a meta-analysis. We found that compared with working 35--40 h/week, working 49--54 h/week there was an elevated risk with lower confidence bound below 1 of dying from IHD (RR 1.01, 95% CI 0.82 to 1.25, 11 studies, 284,474 participants, I^2^ 13%; [Fig. 12](#f0060){ref-type="fig"}).Fig. 12Main meta-analysis of cohort studies, Outcome: Died from ischaemic heart disease, Comparison: Worked 49--54 h/week, compared with worked 35--40 h/week.

#### 4.4.3.3. Comparison: Worked ≥55 h/week compared with worked 35--40 h/week {#s0340}

A total of 16 cohort studies with a total of 726,803 participants from two WHO regions reported estimates of the effect of exposure to long working hours on the risk of dying from IHD when working ≥55 h/week, compared with 35--40 h/week. These studies that we pooled in our meta-analysis were somewhat heterogeneous in that two studies defined the outcome as a fatal IHD event ([@b0145], [@b0335]), whereas 14 of the studies defined the outcome as a non-fatal or fatal (or "mixed") IHD event ([@b0330], [@b0480], [@b0120], Hayashi 2019¸WOLF-S, Belstress, WOLF-N, COPSOQ-I, HeSSup, FPS, HNR, DWECS, COPSOQ-II, NWCS). Applying the same criteria as in case of acquired IHD ([Section 4.4.2.3](#s0320){ref-type="sec"}), the heterogeneity of included studies was judged to be low. All these studies could consequently be included in a quantitative meta-analysis. We found that compared with working 35--40 h/week, working ≥55 h/week increased the risk of dying from IHD (RR 1.17, 95% CI 1.05 to 1.31, 16 studies, 726,803 participants, I^2^ 0%; [Fig. 13](#f0065){ref-type="fig"}).Fig. 13Main meta-analysis of cohort studies, Outcome: Died from ischaemic heart disease, Comparison: Worked ≥55 h/week compared with worked 35--40 h/week.

4.5. Additional analyses {#s0345}
------------------------

### 4.5.1. Subgroup analyses {#s0350}

Subgroup analyses were performed for data from the main meta-analysis (cohort studies) with comparison between the group worked ≥55 h/week and the group worked 35--40 h/week. These analyses include subgrouping by WHO region, sex, and SES ([Table 6](#t0030){ref-type="table"}). These subgroup analyses found no evidence for meaningful subgroup differences by WHO and sex, but persons with lower SES may have been at higher risk of acquiring and dying from IHD with a potential dose--response relationship observed ([Table 6](#t0030){ref-type="table"}). The forest plots and results of additional subgroup analyses are presented in Appendix 7 in the [Supplementary data](#s0505){ref-type="sec"}.Table 6Summary of results from subgroup analyses on long working hours and ischaemic heart disease, cohort studies.Acquired ischaemic heart disease (IHD) (IHD incidence)Died from IHD (IHD mortality)**WHO region** p = 0.89**WHO region** p = 0.16Americas 1.12 (0.92 to 1.37)Americas --Europe 1.13 (0.99 to 1.28)Europe 1.15 (1.02 to 1.29)Western Pacific 1.30 (0.73 to 2.33)Western Pacific 1.63 (1.01 to 2.63)**Sex** p = 0.99**Sex** p = 0.99Men 1.20 (0.80 to 1.82)Men 1.21 (0.97 to 1.52)Women 1.21 (077 to 1.91)Women 1.21 (077 to 1.91)**SES** p = 0.05**SES** p = 0.05High SES 0.94 (0.72 to 1.21)High SES 0.94 (0.72 to 1.21)Intermediate SES 1.10 (0.78 to 1.55)Intermediate SES 1.10 (0.78 to 1.55)Low SES 1.43 (1.14 to 1.79)Low SES 1.43 (1.14 to 1.79)

### 4.5.2. Sensitivity analyses {#s0355}

Sensitivity analyses were also performed for data from the main meta-analysis (cohort studies) with comparison between the group worked ≥55 h/week and the group worked 35--40 h/week. There were no meaningful differences by outcome measurement and by risk of bias ([Table 7](#t0035){ref-type="table"}; Appendix 8 in the [Supplementary data](#s0505){ref-type="sec"}). However, studies with any "high"/"probably high" risk of bias in one or more domains may perhaps have reported somewhat more elevated risks than studies with "low"/"probably low" risk of bias in all domains for both outcomes ([Table 7](#t0035){ref-type="table"}), with studies with "high"/"probably high" risk of selection bias increasing the effect estimates relatively more than studies with "high"/"probably high" risk of selection bias (footnotes of [Table 7](#t0035){ref-type="table"}).Table 7Summary of results from sensitivity analyses on long working hours and ischaemic heart disease, cohort studies.Acquired ischaemic heart disease (IHD) (IHD incidence)Died from ischaemic heart disease (IHD mortality)**Outcome measurement** p = 0.68**Outcome measurement**Health records 1.16 (1.01 to 1.32)--Self-reports 1.10 (0.92 to 1.32)--**Risk of bias** p = 0.37**Risk of bias** p = 0.13Any "high"/"probably high" 1.20 (1.01 to 1.41)Any "high"/"probably high" 1.45 (1.06 to 1.99)Only "low"/"probably low" 1.08 (0.93 to 1.25)Only "low"/"probably low" 1.12 (0.99 to 1.26)[^4][^5][^6][^7][^8][^9]

4.6. Quality of evidence {#s0360}
------------------------

### 4.6.1. Outcome: Acquired ischaemic heart disease (IHD incidence) {#s0365}

#### 4.6.1.1. Comparison: Worked 41--48 h/week, compared with worked 35--40 h/week {#s0370}

We did not have any serious concerns regarding risk of bias in the body of evidence on this comparison for this outcome, because we judged the risk of bias to be probably low, and therefore the quality of evidence was not downgraded for this consideration (+/- 0 levels). We also did not have any serious concerns regarding inconsistency, specifically regarding the cohort studies that were judged to be of higher quality. Therefore, no downgrading of the quality of evidence (+/- 0 levels) was done. We did not have serious concerns for indirectness, regarding the combination of the outcome definition including "mixed" (fatal or non-fatal) events and non-fatal events. Our exploratory subgroup analyses did not indicate any difference between "mixed" events and non-fatal events (Appendix 6 in the [Supplementary data](#s0505){ref-type="sec"}), and therefore the quality of evidence was not downgraded for this consideration (+/- 0 levels). We had serious concerns for imprecision, given large CIs in several studies, and we therefore downgraded by one level (-1). We did not have any serious concerns for publication bias (+/- 0 levels). We upgraded neither for a large effect estimate, nor for evidence for a dose--response. In conclusion, we started at "moderate" for observational studies and downgraded by one level (-1) for imprecision to a final rating of "low".

#### 4.6.1.2. Comparison: Worked 49--54 h/week, compared with worked 35--40 h/week {#s0375}

We did not have any serious concerns regarding risk of bias in the body of evidence on this comparison for this outcome, because we judged the risk of bias to be probably low, and we therefore did not downgrade the quality of evidence for this consideration (+/- 0 levels). We also did not have any serious concerns regarding inconsistency, specifically regarding the cohort studies that were judged to be of higher quality. Therefore, no downgrading of the quality of evidence (+/- 0 levels) was done. We did not have serious concerns for indirectness, regarding the combination of the outcome definition including "mixed" (fatal or non-fatal) events and non-fatal events. Our sensitivity analyses did not indicate any difference between "mixed" events and non-fatal events (Appendix 6 in the [Supplementary data](#s0505){ref-type="sec"}), and we therefore did not downgrade the quality of evidence for this consideration (+/- 0 levels). We had serious concerns for imprecision, given large CIs in several studies, and we therefore downgraded by one level (−1). We did not have any serious concerns for publication bias (+/- 0 levels). We upgraded neither for a large effect estimate, nor for evidence for a dose--response. In summary, we started at "moderate" for observational studies and downgraded by one level (−1) for imprecision to a final rating of "low".

#### 4.6.1.3. Comparison: Worked ≥55 h/week, compared with worked 35--40 h/week {#s0380}

We did not have any serious concerns regarding risk of bias in the body of evidence on this comparison for this outcome, because the risk of bias was judged to be probably low, and we therefore did not downgrade the quality of evidence for this consideration (+/- 0 levels). We also did not have any serious concerns regarding inconsistency, specifically regarding the cohort studies that were judged to be of higher quality. Therefore, no downgrading of the quality of evidence (+/- 0 levels) was done. We did not have serious concerns for indirectness, regarding the combination of the outcome definition including "mixed" (fatal or non-fatal) events and non-fatal events. Our sensitivity analyses did not indicate any difference between "mixed" events and non-fatal events (Appendix 6 in the [Supplementary data](#s0505){ref-type="sec"}), and therefore the quality of evidence was not downgraded for this consideration (+/- 0 levels). We had no serious concerns for imprecision, given relatively narrow CIs in most studies, and we therefore did not downgrade (+/- 0 levels). We did not have any serious concerns for publication bias (+/- 0 levels) (see [Fig. 14](#f0070){ref-type="fig"}). We upgraded neither for a large effect estimate, nor for evidence for a dose--response. In summary, we started at "moderate" for observational studies and did not down- or upgrade, and therefore arrived at the final rating of "moderate".Fig. 14Funnel plot or prioritized evidence (cohort studies), Outcome: Acquired ischaemic heart disease, Comparison: Worked ≥55 h/week compared with worked 35--40 h/week.

### 4.6.2. Outcome: Died from ischaemic heart disease (mortality of IHD) {#s0385}

#### 4.6.2.1. Comparison: Worked 41--48 h/week, compared with worked 35--40 h/week {#s0390}

We did not have any serious concerns regarding risk of bias in the body of evidence on this comparison for this outcome, because we judged the risk of bias to be probably low, and therefore the quality of evidence was not downgraded for this consideration (+/- 0 levels). We also did not have any serious concerns regarding inconsistency, specifically with regard to the cohort studies that were judged to be of higher quality. Therefore, no downgrading of the quality of evidence (+/- 0 levels) was done. We had serious concerns for indirectness, because the outcome definition included "mixed" (fatal or non-fatal) events only (rather than fatal events only), and we could not conduct sensitivity analyses to test for differences between mixed events and fatal events, and therefore the quality of evidence was downgraded by one level (−1). We also had serious concerns for imprecision, given large CIs in several studies, and we therefore downgraded by one level (−1). We did not have any serious concerns for publication bias (+/- 0 levels). We upgraded neither for a large effect estimate, nor for evidence for a dose-response. In summary, we started at "moderate" for observational studies and downgraded by one level (−1) for imprecision to a final rating of "low".

#### 4.6.2.2. Comparison: Worked 49--54 h/week, compared with worked 35--40 h/week {#s0395}

We did not have any serious concerns regarding risk of bias in the body of evidence on this comparison for this outcome, because we judged the risk of bias to be probably low, and we therefore did not downgrade the quality of evidence for this consideration (+/- 0 levels). We also did not have any serious concerns regarding inconsistency, specifically with regard to the cohort studies that were judged to be of higher quality. Therefore, no downgrading of the quality of evidence (+/- 0 levels) was done. We had serious concerns for indirectness, because the outcome definition included "mixed" (fatal or non-fatal) events only (rather than fatal events only), and we could not conduct sensitivity analyses to test for differences between mixed events and fatal events, and therefore the quality of evidence was downgraded by one level (-1). We also had serious concerns for imprecision, given large CIs in several studies, and we therefore downgraded by one level (-1) We did not have any serious concerns for publication bias (+/- 0 levels). We upgraded neither for a large effect estimate, nor for evidence for a dose--response. In summary, we started at "moderate" for observational studies and downgraded by one level (-1) for imprecision to a final rating of "low".

#### 4.6.2.3. Comparison: Worked ≥55 h/week, compared with worked 35--40 h/week {#s0400}

We did not have any serious concerns regarding risk of bias in the body of evidence on this comparison for this outcome, because we judged the risk of bias to be probably low, and we therefore did not downgrade the quality of evidence for this consideration (+/- 0 levels). We also did not have any serious concerns regarding inconsistency, specifically with regard to the cohort studies that were judged to be of higher quality. Therefore, no downgrading of the quality of evidence (+/- 0 levels) was done. We did not have serious concerns for indirectness, regarding the combination of the outcome definition including "mixed" (fatal or non-fatal) events and non-fatal events. Our sensitivity analyses did not indicate any difference between "mixed" events and non-fatal events (Appendix 6 in the [Supplementary data](#s0505){ref-type="sec"}), and we therefore did not downgrade the quality of evidence for this consideration (+/- 0 levels). We had no serious concerns for imprecision, given relatively narrow CIs in a majority of studies, and we therefore did not downgrade (+/- 0 levels). We did not have any serious concerns for publication bias (+/- 0 levels) (see [Fig. 15](#f0075){ref-type="fig"}). We upgraded neither for a large effect estimate, nor for evidence for a dose-response. In summary, we started at "moderate" for observational studies and did not down- or upgrade, and therefore arrived at the final rating of "moderate".Fig. 15Funnel plot of prioritized evidence (cohort studies), Outcome: Died from ischaemic heart disease, Comparison: Worked ≥55 h/week compared with worked 35--40 h/week.

4.7. Assessment of strength of evidence {#s0405}
---------------------------------------

According to our protocol we rated the strength of evidence based on a combination of four criteria outlined in the Navigation guide: (1) Quality of the entire body of evidence; (2) Direction of the effect estimate; (3) Confidence in the effect estimate; (4) Other compelling attributes.

### 4.7.1. Quality of the entire body of evidence {#s0410}

Concerning the number, size, and quality of individual studies, the body of evidence is sufficient to assess the toxicity/harmfulness of the exposure. The meta-analyses based on 26 cohort studies in total, conducted in different regions, including a very large number of participants, and taking into account relevant confounders, documents a moderately increased risk of incident non-fatal and/or fatal IHD when working ≥55 h/week compared with 35--40 h/week, with the lower CI beyond 1.0 and a rather narrow overall CI. This estimate is similar, whether fatal or non-fatal events, or combined ("mixed") events, enter the analysis. The quality of studies is adequate, given similar study protocols, consistent measurement of exposure and outcome, and clear temporal distinction between exposure and outcome, including control of reverse causation by excluding studies with proximal outcomes to exposure assessment. Overall, risk of bias of these cohort studies is low or probably low, thus supporting adequate quality. We did not consider the evidence of case-control studies in our assessment of quality and strength of evidence, giver the lower confidence we have in this study design.

### 4.7.2. Direction of the effect estimate {#s0415}

The study results are sufficient to assess the direction of the effect estimate. For all three exposure categories (41--48 h/week; 49--54 h/week; ≥55 h/week) no single study documented a negative effect estimate (with the higher CI below 1.0). In the first two exposure categories, all studies except one displayed effect estimates around 1.0, and in the third exposure category five studies demonstrated positive effect estimates, with lower CIs beyond, or close to 1.0. These latter studies with a weight of over 60% accounted for an acceptable consistency of findings, both regarding fatal and non-fatal (or "mixed") outcomes. Overall, heterogeneity was low.

### 4.7.3. Confidence in the effect estimate {#s0420}

There is limited evidence to determine the level of confidence in the effect estimate, at least for the following reasons. First, while studies include the test of several relevant confounders that in part can also act as mediators, no additional data are available on causal pathways linking exposure to the health outcome under study. Indirect supportive evidence comes from studies dealing with health-adverse working conditions other than long working hours, but conditions that implicate identical pathways from exposure to outcome, such as adverse health behaviours or chronic psychosocial stress with pathophysiological effects on IHD. Second, the assumption of a dose--response relationship between the three exposure categories and the outcome was difficult to determine from our findings. There was no indication of an effect at the lowest exposure category and perhaps a slightly larger effect at the next lowest exposure category. An effect estimate with the lower CI above 1 was found at the third exposure category, ≥55 h/week. There could be a threshold, but this is difficult to ascertain from the currently available evidence. Third, the magnitude of the effect estimate was modest, given an overall pooled RR with a 95% CI of between 1.13 and 1.17. Although even a modest increase in risk can be relevant for policy under conditions of high prevalence of the exposure (which is certainly the case with long working hours), this low magnitude of the estimated effect does not increase our confidence in the effect estimate. Fourth, no intervention studies are available that demonstrate a reduction of the effect estimate because of reducing the exposure to minimal level. However, studies with the comparison "Worked any overtime compared with worked no overtime" could perhaps be seen as approximations of intervention studies, and the two studies with this comparison that we included in our systematic review and a meta-analysis for the outcome "Acquired IHD" found that working any overtime led to a large increase in the risk of the outcome (pooled OR 1.97, 95% CI 1.30 to 3.00, 2 studies, I^2^ 12%; see [Fig. 10](#f0050){ref-type="fig"}).

### 4.7.4. Other compelling attributes {#s0425}

We were not able to access data that could offer evidence for a discussion of other compelling attributes in assessing the strength of evidence. In summary, we conclude that there is limited evidence of the toxicity of long working hours, defined as ≥55 h/week, for elevated risk of fatal or non-fatal IHD.

Additional assessment of strength of evidence based on the Bradford Hill criteria is on Appendix 9 in the [Supplementary data](#s0505){ref-type="sec"} (though note that this is already covered via our approach to evaluating the quality of evidence as described above) ([@b0055], [@b0205], [@b0445]).

### 4.7.5. Rating by outcome and comparison {#s0430}

Based on the considerations presented above, we judged the existing bodies of evidence as:•Inadequate evidence for harmfulness for the exposure categories 41--48 and 49--54 h/week for IHD prevalence, incidence and mortality and for the exposure category ≥55 h/week for IHD prevalence.•Sufficient evidence for harmfulness for the exposure categories ≥55 h/week for IHD incidence and mortality.

5. Discussion {#s0435}
=============

5.1. Summary of evidence {#s0440}
------------------------

As shown in the table of summary of findings ([Table 8](#t0040){ref-type="table"}), our systematic review found no eligible study on the outcome of IHD prevalence. It found low quality of evidence of weak or no associations between the exposure categories of working 41--48 h/week and working 49--54 h/week and the outcomes of IHD incidence and mortality, when compared to 35--40 h/week. Based on the other considerations for evaluating the strength of evidence we concluded that there was inadequate evidence of toxicity based on human evidence. We found moderate quality evidence of clinically meaningful associations of working ≥55 h/week with elevated risk of acquired or died from IHD and concluded there is sufficient evidence of toxicity from the human evidence. Particularly, findings based on 24 cohort studies documented modest, but relatively robust effects of working ≥55 h/week on risk of non-fatal and fatal IHD, given the large sample size, the standardized adjustment for confounding, and the probably low risk of bias on most domains. A risk elevation by 13--17 percent is considered modest, but in view of the high prevalence of long working hours and considerable incidence/mortality rates of IHD in working populations, this risk deserves attention in terms of preventive occupational health measures. Overall, the heterogeneity of findings is low, and sensitivity analyses confirm the robustness of results.Table 8Summary of findings.Effect of exposure to long working hours on ischemic heart disease among workersPopulation: all ≥15 years workers\
Settings: all countries and work settings\
Exposure: worked 41--48, 49--54 or ≥55 h/week\
Comparator: worked 35--40 h/weekOutcomesExposure categoryIllustrative comparative risks\
\
(95% CI)Relative effect\
\
(95% CI)No. of participants\
\
(studies)Quality of the evidenceStrength of evidence for human evidenceCommentsAssumed risk\
\
Unexposed workers (worked 35--40 h/week)Corresponding risk\
\
Workers in the exposure category**Has ischaemic heart disease--------**----−No evidence was found on this outcome.**Acquired ischaemic heart disease**\
(measured with administrative record or self-report)\
Follow-up: 1--20 years**Worked 41**--**48 h/week150 cases per 100,000 person years**[a](#tblfn1){ref-type="table-fn"}**147 per 100,000 person years**\
(137 to161)**RR 0.98**\
(0.91 to 1.07)312,209\
\
(20 studies)⊕⊝⊝\
Low[b](#tblfn2){ref-type="table-fn"}Inadequate evidence of toxicity/harmfulnessBetter indicated by lower values\
Additional evidence from nine case-control studies also provided no evidence for an effect for this comparison on this outcome. We are very uncertain about the effect of this exposure category on this outcome.**Worked 49**--**54 h/week158 per 100,000 person years**\
(141 to 176)**RR 1.05**\
(0.94 to 1.17)308,405\
\
(18 studies)⊕⊝⊝\
Low[b](#tblfn2){ref-type="table-fn"}Inadequate evidence of toxicity/harmfulnessBetter indicated by lower values\
Additional evidence from eight case-control studies also provided no evidence for an effect for this comparison on this outcome. We are very uncertain about the effect of this exposure category on this outcome.**Worked** ≥**55 h/week170 per 100,000 person years**\
(153 to 189)**RR 1.13**\
(1.02 to 1.26)339,680\
\
(22 studies)⊕⊕⊝\
ModerateSufficient evidence of toxicity/harmfulnessBetter indicated by lower values\
Additional evidence from 11 case-control studies also suggests a small increase in the risk for the outcome for this comparison. Compared with working 35--40 h/week, working ≥55 h/week may have led to an increase in having acquired ischemic heart disease.**Died from ischemic heart disease (mortality)**\
(measured with administrative record)\
Follow-up: 8--30 years**41**--**48 h/w150 cases per 100,000 person years**[a](#tblfn1){ref-type="table-fn"}**149 per 100,000 person years**\
(132 to168)**RR 0.99**\
(0.88 to 1.12)288,278\
\
(13 studies)⊕⊝⊝\
Low[b](#tblfn2){ref-type="table-fn"}^,^[c](#tblfn3){ref-type="table-fn"}Inadequate evidence of toxicity/harmfulnessBetter indicated by lower values\
We are very uncertain about the effect of this exposure category on this outcome**49**--**54 h/w152 per 100,000 person years**\
(123 to 188)**RR 1.01**\
(0.82 to 1.25)284,474\
\
(11 studies)⊕⊝⊝\
Low[b](#tblfn2){ref-type="table-fn"}^,^[c](#tblfn3){ref-type="table-fn"}Inadequate evidence of toxicity/harmfulnessBetter indicated by lower values.\
We are very uncertain about the effect of this exposure category on this outcome**≥55 h/w176 per 10,000 person years**\
(158 to 196)**RR 1.17**\
(1.05 to 1.31)726,803\
\
(16 studies)⊕⊕⊝\
ModerateSufficient evidence of toxicity/harmfulnessBetter indicated by lower values\
Compared with working 35--40 h/week, working ≥55 h/week may have led to an increase in dying due to ischemic heart disease.**CI**: confidence interval; **RR**: relative risk.Navigation Guide quality of evidence ratings\
**High quality:** Further research is very unlikely to change our confidence in the estimate of effect.\
**Moderate quality:** Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.\
**Low quality:** Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.[^10][^11][^12]

5.2. Comparison to previous systematic review evidence {#s0445}
------------------------------------------------------

Five previous systematic reviews and meta-analyses ([@b0200], [@b0485], [@b0495], [@b0190], [@b0505]) have lent support to the notion that long working hours are associated with a modestly increased risk of incident fatal or non-fatal IHD. Our analysis corroborates this evidence. Considering the differences between previously published comprehensive systematic reviews and the current analysis, the following facts deserve attention.

First, two of the previous systematic reviews and meta-analyses ([@b0190], [@b0505]) did not carefully define the exposure and outcome, any long working hours without dose differentiation and any cardiovascular disease including both heart disease and stroke were included. In addition, studies with different research designs were analysed together.

Second, with a focus on coronary heart disease, the evidence resulting from the Virtanen et al., meta-analysis (2012) revealed a number of relevant limitations, such as divergence in the assessment of the exposure, limited number of studies included (N = 12), limited statistical control of relevant confounding factors (e.g., age, sex, and SES) and of reverse causation. In contrast, our meta-analysis included a consistent definition of categories of long working hours, identified a larger number of studies from different WHO regions, and adjusted all analyses for the effects of relevant confounders (at least age, sex, and SES). The risk of bias due to reverse causation in most cohort studies was reduced by excluding participants with IHD at baseline.

Third, the Kivimaki et al., meta-analysis (2015) represents the most comprehensive systematic review on this topic up to the year of its publication. Major strengths are the inclusion of published and unpublished studies (thus addressing publication bias), the analysis of reverse causation, the test of a dose--response relationship between long working hours and IHD, and selected approaches towards subgroup analyses. These strengths were also met by the current study (see protocol paper [@b0250]), but additional strengths of the current study are identified below.

Fourth, the findings of the Virtanen and Kivimaki meta-analysis (2018) are largely identical with their previous review, adding one newly published report from Denmark ([@b0120]), without substantially altering the overall effect estimate. Again, findings include IHD and stroke as separate health outcomes, whereas our systematic review focuses exclusively on IHD. While the empirical basis of the Virtanen and Kivimaki paper (2018) is only marginally different from their previous report, it includes an extensive discussion of potential mechanisms linking long working hours to cardiovascular disease. Being compared with these two recent comprehensive publications, our systematic review and meta-analysis documents the following additional strengths. First, we extended the number of included cohort studies by including one recently published study ([@b0130]). Second, we extended the types of eligible study designs by including case-control studies and other non-randomized intervention studies. Third, we conducted subgroup analyses to strengthen the quality of evidence, for instance, variations of associations between long working hours and IHD according to WHO region, sex, age and SES were analysed. Finally, and importantly, none of the previous systematic reviews and meta-analyses distinguish non-fatal IHD events from fatal events, usually both types of events were mixed. However, burden of disease estimation requires evidence separately on incidence (non-fatal IHD events) and mortality (fatal IHD events). In this current report, we conducted analyses for non-fatal events and fatal events, respectively, with sensitivity analyses to compare non-fatal events with mixed events, or fatal events with mixed events. In summary, although our review built on the important work of previous systematic reviews including the 2015 Kivimaki et al systematic review and its 2018 update, our review further updates, extends and differentiates the existing body of systematic review evidence.

5.3. Limitations and strengths of this systematic review {#s0450}
--------------------------------------------------------

### 5.3.1. Limitations {#s0455}

Our systematic review has several limitations. First, while we conducted a broad and sensitive search, we may have missed eligible studies, for example, due to them being published in languages other than English. However, we searched many academic and grey literature databases using a comprehensive search strategy and consulted additional experts who also did not identify any additional eligible studies. Considering the large number of included studies, the size of participants and the number of disease events, it seems unlikely that the overall results would have been affected by this fact.

Second, we did not receive a substantial amount of the missing data we requested for the studies included in this systematic review. We requested missing data from principal study authors at least three times, but the principal study authors generally did not share these requested missing data with us or only shared selected data. As a result, we can only present limited evidence in this systematic review on:•The subgroup analyses by age, sex, occupation and industrial sector.•Dose-response associations between the different exposure categories and the outcomes (statistical testing was not possible).

In some cases, we know that the missing data requested were readily available to the principal study authors, but these requested missing data were nevertheless not shared with us. This has introduced some uncertainties in the evidence that could have been resolved had the principal study authors shared the requested missing data.

Third, the validity of exposure assessment was somehow restricted, not only due to lack of objective measurements, but also since exposure to long working hours was assessed at baseline only, thus preventing the analysis of potential changes of exposure over time. Moreover, importantly, given the purely quantitative assessment of long working hours, as well as the restriction to people's first job, additional data on the potentially 'toxic/harmful' effects of long working hours were missed. This lack of contextual, qualitative data is considered a serious limitation of the current state of research in this field, not just of this review. For instance, in a recent study, a significantly increased IHD risk associated with overtime work was restricted to the group without financial reward or free time offered as compensation, whereas the group with rewarded overtime work did not exhibit an elevated risk, compared to those working standard time ([@b0255]).

### 5.3.2. Strengths {#s0460}

Our systematic review and meta-analysis have a number of strengths, including:•Strictly speaking, previous systematic reviews have not undergone all steps of systematic review (see [Fig. 1](#f0005){ref-type="fig"} in ([@b0510])), but our systematic review and meta-analysis have done so, including having pre-published a protocol and assessed strength of evidence, and this presents a substantial improvement in systematic review methods on the topic.•Previous systematic reviews have not sought to differentiate IHD prevalence from IHD incidence (i.e., non-fatal events) and IHD mortality (fatal events), but our systematic review improves accuracy by differentiating these three different outcomes.•Previous systematic reviews have not commonly and not comprehensively provided detailed analyses across all analytic steps of the systematic review and meta-analysis for comparisons of standard categories of exposure to long working hours compared with standard working hours. However, we have provided such analyses for three such comparisons commonly used in the epidemiological literature across all steps of the systematic review, and again this provides an improvement in accuracy of systematic review evidence on this topic.•Whereas previous systematic review evidence has not commonly and comprehensively assessed risk of bias and quality of evidence using established systematic review frameworks with dedicated tools and approaches, we have rigorously applied the Navigation Guide framework in this systematic review, which should have ensured rigor and transparency in this systematic review.•In previous systematic reviews, strength of the evidence was not commonly assessed, but in our systematic review we have applied pre-specified criteria to rate the strength of evidence for each comparison for each included outcome. This is a novel contribution to the systematic review and meta-analytic body of evidence on the topic.•Finally, to our knowledge, this is the first systematic review and meta-analysis conducted specifically for a global occupational burden of disease study, and, as such, it provides a model for future systematic reviews that will help ensure that these global health estimates adhere fully with the *GATHER Guidelines for Accurate and Transparent Health Estimates Reporting* ([@b0425]).

6. Use of evidence for burden of disease estimation {#s0465}
===================================================

This systematic review and meta-analysis was conducted by WHO and ILO, supported by a large network of experts, for the development of the WHO/ILO Joint Estimates, as part of the WHO/ILO Work-related Burden of Disease and Injury Study ([@b0390]). More specifically, it provides the crucial evidence base for the organizations to consider producing estimates of the burden of deaths and DALYs from IHD attributable to exposure to long working hours. The systematic review found large bodies of evidence from several prospective cohort studies for comparison of the exposure category ≥55 working hours/week to the category 35--40 working hours/week for the outcomes of IHD incidence and mortality. These bodies of evidence were judged to be of moderate quality and to provide sufficient evidence for toxicity/harmfulness. Producing estimates of the burden for IHD attributable to exposure to the category of working ≥55 working hours/week appears evidence-based and warranted, and the parameters reviewed (including the pooled RRs from the meta-analyses for these comparisons) appear suitable as input data for WHO/ILO modelling of work-related burden of disease and injury.

7. Conclusions {#s0470}
==============

We judged the existing bodies of evidence as inadequate evidence for harmfulness for the exposure categories 41--48 and 49--54 h/week for IHD prevalence, incidence and mortality, and for the exposure category ≥55 h/week for IHD prevalence. Evidence on exposure to working ≥55 h/week was judged as sufficient evidence of harmfulness for IHD incidence and mortality. The RRs for the comparisons ≥55 h/week compared with 35--40 h/week are suitable as input data for WHO/ILO modelling of work-related burden of disease and injury.

8. Differences between protocol and systematic review {#s0475}
=====================================================

•Our protocol did not specify how to deal with studies with outcomes definitions being "mixed", in terms of including both fatal and non-fatal events. We added such criteria for dealing with these studies with the outcome definition being "mixed".•The search strategy published in our protocol did not incorporate a recently developed strategy based on analytical text mining ([@b0125], [@b0420]) that was shown to be highly efficient. We therefore initially adopted the two strategies (protocol and analytical text mining) in parallel, using the following tools for text mining: Voyant (<https://voyant-tools.org>), PubReMiner (<https://hgserver2.amc.nl/cgi-bin/miner/miner2.cgi>) and Yale MeSH Analyzer (<http://mesh.med.yale.edu>). We then observed a substantially higher ability of identifying relevant studies by the latter strategy, based on 34 included studies of two previously published systematic reviews ([@b0200], [@b0485]).•Our protocol said that we would search the Embase database, but since we did not have access to this database, the Scopus database was searched instead, which includes all records from Embase.•In the protocol, we planned to convert OR into RR, if possible. To conduct conversion, information on "prevalence of outcome in reference group or baseline risk" is required. However, such information was not available from any included studies. For case-control studies, ORs were reported and were synthesized directly. For cohort studies, ORs, HRs, and RRs were reported and were used for meta-analyses without any conversion, in line with an earlier systematic review and meta-analysis on this topic \[([@b0200], [@b0485]), Page 1741: "Because disease incidence was low in the cohort studies, we regarded ORs as close approximations of RR and combined them with HRs, resulting in a common estimate of RR." Supplementary appendix Page 11: "Our sensitivity analyses also showed that the pooled relative risk for the association between long working hours and coronary heart disease is unchanged if study-specific odds ratios (pooled relative risk 1.04, 95% CI 0.79--1.37, p = 0.78) are used instead of study-specific hazard ratios (pooled relative risk 1.05, 95% CI 0.80--1.38, p = 0.72) (eFigure 8)."\].
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[^5]: "high"/"probably high" 1.53 (1.19 to 1.96).
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[^7]: Sensitivity analysis for IHD incidence by risk of detection bias (outcome assessment) (p = 0.64).

[^8]: "high"/"probably high" 1.09 (0.88 to 1.35).

[^9]: "low"/"probably low" 1.16 (1.03 to 1.31).

[^10]: We extracted the risk among workers working 35--40 h/week from [@b0120] as the assumed risk. (Note that this study provided one baseline risk for both non-fatal and/or fatal ischemic heart disease events, so that it was not possible to differentiate assumed risk for exclusively non-fatal events and fatal events separately.)

[^11]: Downgraded by one grade, because of serious imprecision (i.e., large CIs in several included studies).

[^12]: Downgraded by one grades, because of serious indirectness (i.e., outcome definition included "mixed" (fatal and non-fatal) events, and no sensitivity analysis could be conducted to test for differences between mixed events and fatal and non-fatal events, respectively).
